var title_f18_33_18960="Palpation of flexor tendon";
var content_f18_33_18960=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F78638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F78638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Palpation of the flexor tendons of the hand",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 347px; height: 292px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The flexor tendon is palpated for tenderness or cyst formation. The hand is placed with the palm up on the exam table and with the fingers extended. The flexor tendon is palpated along its entire course from the distal interphalangeal (DIP) joint through the palm to the wrist. If a cyst is felt, passive movement of the finger is performed to determine if the cyst is intratendinous (cyst moves with finger movement) or peritendinous (cyst does not move).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18960=[""].join("\n");
var outline_f18_33_18960=null;
var title_f18_33_18961="Drug packets abdominal plain radiograph";
var content_f18_33_18961=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59782&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59782&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Drug packets on plain abdominal radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This plain radiograph shows the typical appearance of drug packets in the bowel overlying the pelvis. Note the rim of air around some packages, which helps in their detection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert Hoffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18961=[""].join("\n");
var outline_f18_33_18961=null;
var title_f18_33_18962="Rectal prolapse reduction";
var content_f18_33_18962=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F52965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F52965&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rectal prolapse reduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 433px; height: 459px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) The child is placed prone in the knee-chest position on the examination table or the parent's lap. (B) Hold the prolapsed edges with a gauze pad. Using lubricated gloves, apply gentle but firm pressure to reduce the prolapsed mucosa. (C) Digital rectal examination is performed after reduction to ensure that reduction is complete.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18962=[""].join("\n");
var outline_f18_33_18962=null;
var title_f18_33_18963="Endoscopic ultrasound image of a gallstone in the gallbladder";
var content_f18_33_18963=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78437&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Endoscopic ultrasound image of a gallstone in the gallbladder",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 316px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Gavin C Harewood, MD and Maurits J Wiersema, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18963=[""].join("\n");
var outline_f18_33_18963=null;
var title_f18_33_18964="Chronic PE PA";
var content_f18_33_18964=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54915&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Chronic pulmonary embolism",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 302px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEuAV8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5zjjBA4qykOcYFWLW13AVqQ2vHAxQBnQ2RP3l4q3FZAfw1qQ2zEj0q6lqQeRxQBlQ2anHycVbis1JztrRS2wv3TjNTJAQcAUAVIbVDnC9OtXYbRQV+XIq4IdigkYHrTfNPnGNY2wFBD9vp+lAFeS3TPIxUbWyZHGDVlzzycmoi3zd8UANWFFJwuSevNaGnKqkjGM1Q3Ek4BFaOnx4dXJOKAOlsLVHK7lGCK24raPAyuOKydOkAXrnFbKNkcdKAHrDGCeOKmisxI2VUc8jIqFY5SSSOPWteyb/AEcKAfl4PHvQBCLTaPuLVqKzXAZsAe/ahyR2x70i3RQ4JBoA1bOGPcmduB7dauSGKOQHy0yeOlZlpcB8FgRV1XDPGDGcjkUAXo1QjK24ZR/s8CqFyYGmIEaA+4FaiygKEHAA3cGsS7kVpySvINAGnp8cL5DwRZI5+UVd+yWuw/6PDx1ygrJspBuGAQPY1eluSgPH50AUrvTrOQEm3t/xQfyxWPPpNmzc20B/7ZitaW5ZhzzVSXON/wDDQBjXWi2Sjd9kt8e6Cs5dE05j81lAf+ACumkR7lcKuMdTTfsXGCMH1zQBzEmhaYQc2Nt/3wKq3GgaXt/48rcewQV00+nuchHTH1NUZ7OdSwI3DH8NAHK3Gg6WRj7FAD/u1g6j4f09QdtpFz/s121xAwzuUg471gam/UUAcJeaPZg8W0Y/Cqw0ezPW3T8q6K5Tc3TPNRx2+D04zQBi/wBg2ZHFunPpmrln4IhuwDFCm4jIB3c1okYIxXR+F7xLWdUuFJgfhueV9xQB55L4atYnKPbhWHBBzkVGfD1kf+WK/ma9U8TeHJnJu7Uby+CQoJ3DH3h7VyL2M6yYaJ89xg0AcqfD1mWOIFx9TUM2gWa/8sB/30f8a7FLGQ53LtHfNSmzQH7nfjNAHBPoFsR8sB/AmqzaBHg4t2/8er0Ca2BIyD16CgaPcTrlI8Ke7ZFAHmc+hquf3J/Ws640nb/yxbH416y+ixID5vzP6DOKz7rTlC4CgfhQBgWVrkDg1rwWgPQH8qmsLYYXdgVtW9uoI7CgChb2IIzggCrC2nzdCK1o4cYAH5VKkGX4GaAMWSDYCcZPSmpGSeFIrqbLRmvGYsdsY6tjNT32kLDGwiThRyT1JoA5SaNigGfwquYpAx5ORWy0LKOEB98U5YMx/OvHvQBh+SxY7siopIirYrdNt8pAXinw6TJMfMICx/3iOtAGJbWzs/QnPQVs2OmStjeDHn1HP5Vq2VixIS3i57tjmugsbGKADz3Bk9AM4oAraZoqJGpkkf1+7W5b20MWSqE/XvVaTUrWJtoQttpU1nf/AMshj+HAoAvuqHgoAB0NOhymQBuVjz7VmN4ggRtsiNge1WodWtGj3q+AexoAuMi9sgelQeXF5ozuHOOmahbVYW4Iz71PbMsyFosHHp1oA0IY0jRdik/UYAqy0zKAx/DAqvaB+FPI9KsWxnaNfPh8l+6Eg4/KgBk168SFmR9rcbsVmicTScNmtfVgVgXgHsPyrMhCg/6tAPTbQBfs38twBzmrswBLM5I46Y6VTiyJRtQD8KuMC20E5OaAKcnzEjHA9aTy8oVIBB6mrTxYyR1+lVrqeG0gMty4VBQA0B1GMYHvSnI+8eK5DWfG0Efy2qjA7n/9dctJ4unZ+VUj8f8AGgD1NlQOT5mOKiKqSQJBmvPLXxWNwEiCtyx123mkAdeMdqAOjubVhCSqhjg5GM5ritV0tJHYoTG/90jiurguI5sm2mw3908VFfjejedEA3qOpoA80mtmhmIkBBzgEjj8KkaDbH0611kmnrMOAJEbqCORWZcaY6MTFlo16juv+NAGALfIFWYUKgEVaW22j61OkOBggflQBqaVq91bxqjN5kQGAj5IH09K1pVsNQVmHySHqQOlc/EuHxwfar/2KaYiO3G0ZyT74oArXel4Y+SRMvbbn+VMg0CaYgyKY09CK6WwSO0QCRfMcfxY5rUKtMAcAxn8xQByq6TY2vzbd0mO9RXEYZflUBR6V01zZQxqXzuI7Vz99fQRbkC5I9qAMO5tcqecn6Vkz6cWIyK3Tdxnkoaga4iGCELe1AFqHwzauq7Cq/8AAaSfwvcxqDGBIoGeOK6S3Q7cBAK0YA+BtoA4BtOuYT80R/nVqz06adwqoR+FeiRxrgFkQ/VRUyxWxQ71UYPYYFAGFp1gkVmWbAjQfM2OpxWNqZW6l+RcRjpx+tdNq0BuIBHbsFjHIUYHNYL2UsR/eIQPWgDL/s4EcAd6huLLZGAVGfWuhjjyvv3q1b6esrh5Fyo6D1oA5yx0sMVll+5xhcferRkslAG8YA6IBXQNZpGgeT5BjpwKw9S1CG23McKg/icgCgBsFmyhmlcrGTnbxhRjp+lYmq6zDbkrEoAB79T+tYXiDxaZsR2rEgd8CuQa6kllJc5JPU0AdXca4ztlQFFZs2sTzSHaxArGup5AgVcDPHAFVkmk3YDUAdaLqd0UZ+UDnNE5MqB4/lI6Gsy1vzH1wQR0NX4LpJGXaoOetAF3Tr6aOUJcYIOMNXW6LKxnVoSCc8gHrzXJQwrcMdvUHit3S1kt8AZFAHolrOXwGAVuOgqXf83XkdTWHp0z8Y5OATmte0mWV1WQde9AEep3XmRKihsg1WjyCMhlJFX71dkhKgY7H8Kz5w+BgcHvQBrQSEyAkA1YhG5mJNZmmqScGr/niJzk/X0oAbql1Fp1k9xLzjoo7mvGPFerTX120tw3sqDoozXSeOtdMly8aN8ijaB2PPWvNr+SV9zNye2SKAKs15jouarteSg4ULx2xmqsvmAAnB7dRVXe+TkigDS/tCUccZ9hWnpeszR/f2kHpkdK5/aWOcZz6VMAy8bSB2oA9As9XXhiGT3HNdTYa8ZIgsgSde47ivKrecbRzzUy3pjbOfyoA9QF3b/akkhLxMT0xx/OtGNEuWLDaJM/eHQ15lp2u/OFuPmQdCMZFdNoOrxu2YZMqTypIzQB0Nxpm5shFV+wxwazpbdl4K4YdsV1VkRdRKU+fA6dxVw6dEdryKC9AHOadpJkCTTAKg7evFaV0mOIQqA99tXAQCVIAUdBVeaUFWx1oAojCHLHJPYCpZr77OgY8HsKpXE4Rn28t0zWYxaRyWOSaANGfUnnbEgKg9CtVprMXKsUxvPeprC0EpBk5T0rUFijD918hHTPegDjJ7R4yysMYqOK35x3rrr3THkj3NGQ4xyOc1kx2U7vhIiMfhQBYtr26YjYQAe2M1qQ6lNEApKseCcVUtoDEoSMcnqaseWkJG0bpPUjgUAbNlfj5fPwueAO5qaWdXbA4A4Fc8srGRctk5qwkkgm4Py5zQBflVt3yNmlllEMQMysykhflXOM8VWhn+fPOT+VaMTiQHvnvQBEmnpO52HHc4rRFsYFzgHA6CrVpCEjGCNx61m+IdTNpAY4iC7cE+lAHNeJdfjtHK5Ekg/hB6fWvOtcv59QJadgFPRR9a39Stlu5WbkM3X3rJu9GnhQlyHjPPynmgDlbi2AIIPFMht8tnByK3TEiKp27vrTdhMm0fUe3FAGFc20jqWIC4Hc1Vt7bJLM/PtW/Pblo2BI3EdzWQU8slWYZHpQAPETJiNh07mtSzhPlhlI39+az1T5gQwz9avxSMqqANvHJoA2tNnIl2S98c11NmBDyeQxGK4y0yVVs/8A666Cwv8ABVZ8Hp3oA6+3n2bWXAFX7CX/AEkA4I7Vj22yRFYNgEcCtC3gYYIkwvfB5oA0ppRJIEJHHoaSXIUY6ZrMtY/LdiH+XPetRwvlB+pGaAFhl2AMxA4xWZrN6yW07bgDjaPrmluZmJY54x+Vc/rlyzxZb7q5x70AchrMqkMWJZwevbNczcFpUYseRWrq1yryEbuB2BrDurkcquCp7g0AUpwdw7E1Vkj5+8M/WnTswAIPXmqzHOM0AXIVywXI49DzVhwQQqk9ay0yOc/rVyJ5MqVY0AbEatgK4B96fLaxliVYj8aIpm+VQFdj1zWhbxea4Ur5eTzk5oAyTC6KCoBB7ip7CC4FzG8bFMEHPpzXUWWkR8OsgkYehHFTzQoZNvGT3BoA7DwdrEQCQzMFlIA3k8Ma7KZQwDKRgjP1ryS2iMLKynkenau68Pa2k8a2txIPMAwCTQBdvAB+87jqM1kzSkudvT1rZu4/MDMTz3FY8yBaAKk0II9PYVEIcA56VoRjIz+NK8YYUAMsWwAmcYq5u2nBPHpVOBSk+f4SMVO6/NQBYhuJI5FOeCemauTmMFWY9R61izag0ZVAilQOhrQtpkvrMGNhuTGRnkUANtrNwweXAHZe9WZYQykHkZoG5QCc89aeCSMUAZS2xWcHHSpdnBHrVyQBSRn5j1qHy+QPxoAijTHfIrSsIiGLHIPp6VDBBzuYfL/OrcjFIiF++2c/SgA1DVBbQtsycZ6Hqa5a8uxcvmZiCecNVnUpBnGfu5zXP6lJGsPmSHAHT3oAuvCGI8rAB9O9RylYiFdgMfjXMnxFJC+IgREOME5PX1qe21SK5YEHa/dWPX8aALt41rOmBBkg5BJrDu7GYsWik2r1CjpWwqErtUHPUU64t3aIYXB4BoA4/wCzXIlXdk4zkL9Kx76Cbzmby5OT6V6Da2iJIHdiAO1S3On2qrJIYg2RxknrQB5ijSrJnJ9DmrQugSmeD3rpZ7SF5dqwAc988UsmjwxZJjBz2oAqaTOHfyy2RjituFA88IXPP+NULbT4YJFcIRgg9TXS6e8KTxKkYB45P1oA3NJgITbcZUEAjOc5rVhHlxnHQVDalZfvZ6d6muj5US8de9AEbYZuuCK0JDi3BB7ZxVBlxJv5wTippZRswOBQBUlceW+eSMmuY8Sttsssx3HJC/lXRXIcKSQVUDmuR10mR8nOBnGelAHCXUMtxI5TdjPSqI0+5bkKSvfA5rqUcKJlK5YgH6Vni4EU24547DNAGDcadMCDtcqf9k1WXT5jIAqE/ga69b4hcMwdD60nmmFlmKqc9KAOXOmXGQCoUe/FXrfS2Kgyg7T2Ga0ru4EjbliJDe/etC2w8CAx7SvJ96AK1pCtuw+XDY6VayqfP0Gfu+lXomjMxYxkjsKiuIY2kDDCIeeTxQAkEsgUshKD1BxUcl+Ff97yAfv5qtdXsUKFIz5pz0XpXO3FzJLMzEkr/d9KAOwh1RZGCwMWHds1r2CP/rEJV+uQetcBYzPA6snBPb1ru9Avo7mLYw2y8YHrQB3uh332q3EUpxOg79xipL2Hkso+U9vSsGwkME6tnDCuofEy7uqNQBkYKL1p0RzxU1xEc8D/AAqFFw3SgBHO05ApWbcmc0kgJ7fhUDFgD6UAVJxuJJJxjk1a0B/IuBySDkH34qpLuG7jin2GckrwaANm3nkI/eHcp9atRtk8f/qqmhAA6VaTaVwKAEYF5Pb1pYyzE8DrxTsYA9T7VNaxnqwoAsQr8oAGOM1XuyQHcEd+avbSkTEjBPaud8Rah9mhaKPG/HPtQBg63feUWyQX5wOcCuOvbiSR8u5bOeOtT388ksh2qWJJpsMBUKJBuPYCgDE8iVnYJ93PU9qhlkeHockfhW7eRHB2fe6Y7VhXrJGjByNw6gc0AaNpr08SIAwIGOGGa3bfXbeWMCYMjnqQOAa89a77RjjHU00XbtgE5NAHocV7C7qRcKQT93kVca7Ro9rsME/nXmyzFVAJ61Okx37GJ45GKAPQWgUkurAqB9CKrylpmCkZ5xxXGz6hKGA8xwF9D1oi1a4wDvOR3oA7SG0aRSu1yQOcCrcMTwMgKE545Fcppeu3MUo3SEqSK6ixv/PlRXOQed1AHWabtkRG5BUDP0q/crC4j3euay9PljibaDuyOg9asTsXcLxwBQBeOzyunG7INRT8REhPfpUqsvlouOQKtgI6YxntQBj2lvLczOj5xjPNMv8Aw7FIv74nr0Het9EERGOO3FOnYPgZ5oA4N/C9oJyQjqWGDyaxNU8I793ks4x7Z716eLcn5sA0otlbsB60AeDnRLu2u1SdHWPPJI7UXoiZhF5m2MdGr1bxVpX2628qMhcYPA+teNazpMlpI2doOcZ96AJViS3+Z59w7Y5q/b6tFZQEqpmc5x5gzWLZrIFCOAe/NQ3hYMcgrzigDTn8R3UsjYSONR2jGP61XF00x+eVjzn5iayndgQCBmgkjA75oA2mixHvDEknjFVWRSSGzyetVku2j5j+U9/SpEukkP735Se6jigC7BCMAod2PatKykkjAKHBU8EVWhRRHHsbk9cdK17aESxIpwjY6460AdRo18LyNUlOJxwOPvDH867LTnL2+xuSORXltqjwTA5O4c16Hod4twAw4ZeGFAGlIu9cgVW2gNWjcLhyQMA9hVCbKk8d6AIpVBP41WkTOc81bHJ6VE4HNAGZJkMoAyDxUmnj96RtPT8O9SSoCQcHP0qWwTDknORQBYVCOo74qzGucY6+hqNOevT0qxGOQaAHMOR7CrtovAPXFU+d1aFqNwC9cde1AEWrXAtbIyH73QD3xXn+oCS6mY568kmuw1wtO+1T+7Q1z16qg4UYx+ZoAwfsyxkjaN5yCaqXwW0XzGIx2Xuat394kKMI8NLzlsZArnL1zMpYklz1oAjvbwzIwjAXucdetYc4AY7hz16da0fKLN8qk4pt1aErluOOOaAMSSNWAKflTBaSvhlUmrgRUOFGDVy2UFAXyGBxj1FAGfBA0nyuQrY7VfihjR84LMB3oG3z9qjnPJOKPtSxTMJjkdiKAEu7WNwC8YUPwQPSqtpbLbyCKTc4DFQT1x2zW8sa6htaBkwByMjIxWbq3lJIFiIaTJ3EHgUAWBp5ZgUBx1rb0dXjkQtwoYfzqn4cneRArEMBwMgVv7VXJ2fU0AdLYRlpIyMY6/WrN8xjclRx60miRrLGp/2QfpUkqAkgMMe9AEto7yeX6YzWzC2F6c5rPsogLdSDgdM1pIAoHFABIC7jAp8acjIzioy37zpwafnB560AWsYHQdaZwxIIGKjLYHWmiTDFu/rigCtqMJ/g+leV+ObBlYtt+71wPrXrDP8A3ua4vx1D/wAS6aTHIXHWgDyZ59qhtoBAwDTShkDFuT15rKhmfcybskHitZblxZjeoOVODgZoAqz7Q+cDimNGuzcOMngEVA86O+XDA4q0VyIyuCMetAEYtnAGBkEZzR5RjTkc1aDlSDyOwpWxITu6+oFADtNeSGZWAyD1B710+nSC5k/dHGOdtYcNu0USnGd2CT6VbtSY3DRDHOc4oA6+GLcAJFHPQ+laOkFrG9RyOCT+IrK0q7E6gS8P71vwRZADjjsaAOzPzoDwARVC4TBIOM1NprF7UK33lp1wvQ4Hv60AZyLz04qOXksAvFWtucY4ye9QOuCeOaAKpUnr9antADVd35xwAeKsWZBPagCwo5znmrAyseRyaiXr6U924A7UASQ/M4rSth8pPANZ9uCc/lWiuUiFAGZcjIbniuO1u7KM8UZDMRhm9K6bWrjyIzGp+Yjn2rjL5MyttJy1AGLKBlhjls8VDFZ+YBuJReSMnrWv9h2NukOXX34FQXUMkq5UHOaAM11CBkQZHrVQmRgytgk9jVqa4jhUpJhpP7oPv+lZN5eyyRsF+RPQfWgCS5hh3LubLgfdU1nC4+b5DtIbgVWldvvI3zVCtxk4YY7ZoAsXrMW3kj6/hUTKsiByccdacx86EBeo71BOStuoYYOeRQBPaXklpO5hcqCMVnXd0xkYk87iTzRHISwzk5qHUIXUqSMBqAOq8H3yPOqOCCTgGvQkiWTaIzgsRnNeUeFCUvY/dgP1r1jQg0kiIR0Ix7c0AdPo1s8URL4ppiJk4Yjnv1rWiQRQKFz9aqyIC3B70AWIU/cqM8DvmrWFK9TVWNhhVzVmMjbx2oARlAX5aRmJpJHUtgnBpyDnjrmgBVHvk0jggc1MiZHp9aSQcUAVMMSMiuH8f6gsNoYxgsTjBP15rupW2xk5AxzXknieW41G6kkA/dr8o/WgDzTYVvyCMRkk5rXmbeqqDlSnFQ3UD+aFOM59Kv3EKi2VhxtB4FAGG9uFf52Ge3NJK5C45GDxTAHkmcsfl96cCzZA596AJYJ5FYeZ86DoDWpZRxTkFcq/ZSeprMHylPX3p7XbA7UOB3NAHSxsbZgJAc4zjNXYitw29flb2PFc5ZahIUKSgyLxjnkfSt+xkVgphbcvT3H1oAvW4khYbsAA5FddpVyLpAG4YcdawraNZItrjOfTtVy1ga1nDKxZSaAO70rIJQ9cVZlX5TnqDVLSpBKd6jPGK0bheeOhoAz3+vINQStlTjGT1qzIMfhVKUnJ96AKkvGPWp7IDPbn1qvMCTkfWrFlww+nSgC3Hzgrz71KQS3NMTp708Z28flQBbsxnoMVdnYRx72PAFV7NcJ+NGsMwhVFGTxQBzF/vllY9yapSQLErbsPJjOQa2LlFSIsR8x4rHumWDfLJnGMgZ60AUncKjORtHPJNYOp3khx5DGNR1IPJqbUrlpiGBIjycLk8VlzyFUxj5D69qAMy9+bcSDuzn61QZ8jBPI/WtCSNpXygYg9/SoLi0ZQeQH60AZx4GCp+tRfYneTgEKe9XghTjG48fhU0OcjaMjoQKAKNvamK5wxJUD8OlX8QpJJFIBiVSAT61ECzXDBATnjmpVRZLtY3UArznJwKAMx4FtiyyfMeduB0qNkE4HbHHNaGoQAXLgsPQjJp1tYCRY9rDg8j8aAI9CtGF7HjIKuP517Bolm6fvTg5xgiuN0rRJjcRSIoU5GeTXptjH5FrGGOTigCw8hWMAg1AzCQH1qTduGT3pQqow6CgCqWcEY6+1X7WcsAp4/rUZgUJuIpkR2scdqAJ75CpBHT1p1q5J28/jUhxNAQTyOlMt8A+h6c0AXo8cjnio5iADz+NO3cHHUetVZ8nvQBWu3AjbGT2rhbtU3lWwFJ6V2txGXG3nnrXM6lYmSQkCgDl5NFF1cB4zHnORnNR6npAWRow6HK8gN7V0MFuIARkE4xn0rmtZxFfuxkwSOvPtQBxur2MltPtVCVzzxxUERWFduMuw/Kur1K6hEDKcSAg4LfSuVj2SzYCndnGRQAPgphuSfem/Zspwu4n36VdkhWNAPl3e5pY5CqDYoPqaAK8REQA2HPfk1paW8qTK6Nsx15qtGPtDkOpHHHtV+3snjQHgn260AdXpt4J8Do+OR610FkQxwQffNcPZs6MjLwR07V2Gi3QkAV8CUnkZoA6bRw0M+Cfkboc1vSAlRxWHZAAcjmtxiSinPagChMOtUJwMnjpWjOMOR1zzVKfAzgYoAoyAKfwqW2PzD6VFKc4wTTogQODQBeQZGc4/Op4/mVefrVaPkAdvWrkC5IHHNAGhaEBgO1F8m8A9xz9KdarhyaS4+uBQBiXGFQlzx2BrltWczyMDwB054rb1yUklAOBzWDMplJVh16e9AGRNB15/wNUbuycKsj5CenTPNdB5XkffAfgjkdPpVGSQSbv3eR79KAOf8+SMlBgJ6D0qCabLbyg+lalxHbxqzTHb6etZl5NF5LIhAAI5xyaAIg9uF/e4RzyOtZ6agY5G8kDn15qLfEj4dW59qq3G3cfL4Q8gYoA0bWUTXCGR9xLYI7mtDXtS0+GREtVBkHBIBxWDYKzB2C84K49KkudOLMrLlx7dqAC5l+0HzTlWHXFbHhJDLe/OPkH5HmsdbZy+0Kc+ldr4a057S0j8xdsjZJ496AO4hMENsrADcPrVu1vhKhB4HasmEM0IDjnoau2sQCZzg9+KANyLayDHIxUmFxnnGKis4wFx7Cpnwq4/pQAq48vFQYKE4AIqUZK47U0jPUAH2oAfE+CQB1oXO7HGe9JGCG6Cl48wGgCyvC885qOXp0Bp8fOPUU2TgjmgCoyfNnmqF9DtUEDOTyK1yoYgsBgcik8rfndjGeOKAOGv5BbmQuvAU84rzzWrtZ3m8vc0hPyr6cV6v4hsI3hdd2zcDk4zXGWFpp2nzyzOn2qVvlBdAFX8M9aAODu0nCrHOGjOP4gciqJnESlIW+YHnivQvE1otxbme1RGODubjI4rzZ0cOy7OQT/OgCYtI7BmbnNW4pJDHyuVB59aoxM2NoGQOelW4EYnnIHegDTsVD8QlgcZx3rWsWII83kjpmueSQK/ybvbitbTrvzCFnGYx3xyKAOht0juXAC4HqO9aUSvDL/dI6EHrVTTkTarRHMfTp/Ot+3i85DvCgDuByKANzSZvOiPI3Ct+D5rYckkVyFjvs5skZX1Heuutjx8vTrQBFc8AH8Kzpx1wCR6Vo3QwCfXms+Xdk4xj1oAouABjmiE4IA6mnyr8vv2qNV3DqVPqOtAF63wVBx+BrQtuGHHQ1nwD7vatC3A3rigDQiG1T71W1KTYgA5PSrceCDWZeMJpW9BxmgDCuojNkj6E1nyxhBtUAnuT1rbuSoRkH3T+tYd9tQEEldo/P6UAV2RXHLYNZOoTrCu2JVbOQWNMu7su5WIlVwTgdfxrPm3P98fMBn60AZN4DJKxJ3Env6VmXCOvAzz2rcGASQgwOQSRVC9nDA9FP0FAGSHZ5Asijr3ogmRJlDxrIhBBAHNRyMzsokOT2xxWloOnPLeKdpdAfr2oAvaBbrHPvkjVomHCsK2ZooFi2xIqJnqBirz6cILZZY1beeob1rLuQdx3ofc56UAbWmaLBMfPymF6ALXYLao1mjIihumdvNct4VRyjAkndyPTNdhG3kog7+hoAzpEKg7h+FS2aEg9qlmZXdvUntV6yiVUJOOfWgCa0G1QM8/SpHAJwePSlj+gAoIHegCLOxWLcfyFPX5c5pJYlljdG+6ylTjjg1DaRTwvKs0pkiyDGzH5gMcg/j396ALaKMk4+ZqcyfPnv7ikA+bOOtSyuEZQxUbuF56mgBIxjPQ+9RzEk/4VKxYD5QCM881XkU+vJ60AOhIbJA9uak3HoAATVLlRkZqaHc5HGM9aAMLxZDIYzIqtsQckd+K84upPtLbUBRVbGAuSa9W8Q6cbqydPmHB6H2rgodPNtFcJOMMM7eQSaAMHUr144fJtIh8gO4HvWDczRtal3gjR2JyQK6G2WMXjxywOS6nD8YB46/n+lc7dwQRXbxu5Me45zgUAZjIxI8rG3p706N5EyGBq6xQP8gCoOAKkIgUhXDFm6YHAoAbbjzFyFwxHGas24YYAUdOtQiMbsICR6NU9sA0qnyQWXgFh0oA29IkeAhgflz0PQ12NhNvCui8dx3FcbGNqooIBHWtaxlmjkynrg+4oA7RNsnBXr6CtvT2ItgG+8px+tc5pU6ynI4x1rodPIDhD0IyPzoAlumIXgZ/DpWXIzHn8uOla0oUM2fvdDWZKvBXjjrx70AU5XJUjgelRK3OAc0+de/GMVCvykZ4HtQBsxDBGKuwcyL+FU4eOhq9bfez7UAX4eVPXkd6yphg8dzWsn3M+vFY9ywjZixwB3JoAz79hGhfiuZ1d5J8OrAADp6VuXkwufvDgDjmsW8QqWBwMg5zQBhCMuSA3zAdKplXjJ5xg8HNWbhjBIApGSThuuarSeY8hIBIB+agDNunZHYuSeexqlJE0nzYAjI6mtu8tkb5m6+x6VnX4ZU2sfp7UAYzRorExklumTXb+EbGRbQNnrz+lcYu/cCpHXBr07w7dR2mlIvyliASWPA4FAG15EQtoxMwAHJLHrxWNry2roDEh3KMAnvVidZbuIM7YwOMdKzZ3bZ5SHB689aANfRAYQv8AdPXitaVmll3o2W7DtVKKVIoNrD5zxVy1JDDacDrQBYgOw4cYfqac0heQkEBKhuDu+bPJ9KjgckcHkHFAGxasSuGI56VOU45INVbXoMEVYySAaAE5DDptApz4LcGkBOacR3zzQA5cZ5/CpZOo/rTIeCakYhsAEEj0NACLwM1C6jk571YHQjODUMhIwMfjQBEVGOBTRwwI4p2ABn+tDKSMg0AE0gKD5se2a4vxPHIZZJIWBZOo9RXVSgqc5GBzVC6shNulXjA5HrQB53dXsCJs6nqRn1rkdctw10xQNtPTPY12HinSZIp/tESnafvAdqy7yDdCJhnPfmgDl/KkRYwME/rWjAiyxJGDtcHoaj1B445ouRlR61DDcPvAQjOaANKG1aNju+YnsDV4DKqNox7npTbORpUAbaCo/iOM0/5pHzu/DPSgCe1gCoNuX789a0rZzgkBiAfWoYGIRcyKO2O5FbEMKOFUMee460AXdLYQkFO46V1lkclCDz2rlYQUcA4x61v6bN+9RTjk8UAbUyjqOD3rMmwHYD69a1WIKYPUVmzcHIGCaAM24yR3OO1Vm3cBNu/371dlBAOSM1VRGMhJdtpAwOOKANW36D2q9bN1x146mqNvjqPyq/aKCWPpigDRyNg+tc7rknzlBgKDzz3relYLbkn1x0rA1GMSE7uh5/GgDHVggJIzk8VUvpUGRKmcjip3yGITJz0GKbNCoAd+ZF56dKAMa4s93O3K8naOoqjMs9u2EQ7ewFbc7gYOTv8AamXUe9Rg4bt/SgDLWAXasREVZeuehrK1OwYO5Vs98A1av7u4ssqrAjPNZF3fu2HWQEkcigDNkieOReM459hXVaeZJWt4kcBioJyeOlcg12wfA3Z6EHmuk0uTzIInjfbKuMkZzjFAHpGn2hFgHkKkt1Az6Vga6Et7nczKM9sc0keuXMKxpjK4xu7Vl6pctqd4rbQoA6nuKALq3plm2JlmHBNdDFMRAij0+961hWNqsWVAI387/UVtKgMabTkAUAWogGQ/Mc578VEjMkoXaSSeoqa3zgYH14qUxuZAwU/lQBo2pIXkYqy3IqtEhyMnmpyGVfWgB3bNPNMjHBz1NSFeAM8fSgB0ZwW5zzinMxzxnmgAcmkHJHFADh1xzTWU4x1pxIC5JwBTd6nOGH4GgBjRkj39qbgr1FPLHoDmh13gZ+tAEE6ErkDNQROVJXaRzzVqRiMdwKj+UsWK4+lAFPULSKZC5ACYy2R2ry7xHaz2csrAB7RiSoXtXrM4MiEIAyHisi/0mO4gaN1GwjGCOBQB4bNaGeTJO3J/EVnqJI5iAD8pxmu18TaFJpk+4HMRJwQPfvWVaWkTSAsrc98cUAUdOu2jkIlYnjrnNX7S4MEmZPnVuc9hUMmnNC7s6kIOhxwagG4HkHYKAOjtbpZCCxIJ6e1b9tPyAMlfUVyVsSUR4xlV+UjHtWxZzyRSLgbh6HNAHX2QBA34PvV+1UrcxsDkA9jWTZSBlypP+Fbdhh2WgDeDAxk9cj1qpc544PvU0J/dkY6Driorg/u+vSgDOmAHYmoUPzZxkCp5u4/lVcFVBLHgdcDNAGjCOB61oWy4Xvk1QhPPFaMJAK8dqAJbvi3xjvWVcxGSPC53CtW4+YMO+KpR9OnNAHPzwC34Q855bFVZy0wYAAHHWtjU0AQjPTkVzt5eCBTtUFyCMmgCvO6wY5Bk5zWXfXTHkEjOcbeMU+6kMuMMV4z061n3Ev3owAC3U+tAGVcs7SsZ2OQehz61Vnt/tBxGQOegHStYxbB85Uk/3uTio/s4iZpIznPIFAFKw09kWUywErwA9dDpdo6xfukxn/ZrPtlupJoml+SJRwD3rUtr64EiqVAG7HI7UARPKIrwQyhtpHykjv8ASo9RV0uo9gJH+z0FXtTsxeYIAx0LelVJUOnjbncuPvEdKAL2k3kpunglcfLz83WurtwnkKApznvXmWnT7fEHmdd/y5P4V6nbQ/ucE5zz0oAs2seMe/WrIjMYJ70yzG0fMc47VYlZTyOM0AJGzMc46elWTyAe5qvEoHSrK/cHegAHYdcVKANpPWoyeakzjoPxoAQk/wAJ4x3oGcrn8aYc56gClUg7cHjsR3oAkzkYJ4poVATtUZ+lLjByRRjA7UAIx9M5oUk8YxSdBnilyBjjmgBj/d9O1RgAgg5OOlOkO1MnpUa5BOR2oANuwYA6flVSeU8/MAKtty2T3qneW5B3A49qAMrWrCK9tcygEHqK8t1+yudOmIi3tadc8/LzXr5AeEA4wO1Zt9pQuI33KCrHHTPFAHlOnamZGWGb54u4bOa0/sQuIjLbMGHdcdKm1fwlNZ3BuLQF4e6DHHv1qLTbk21wCgBXoQKAK8W+1kCOpAHJ44FaltIrDGPmHcU6cxzSKzKvJ5NTi3Eb+YiAjtjpQBdsZNgZskkmuo0Zt7Fgflrl4l7L1HXFdFoh8sgdeOSfrQB0UHUgU2YcMpOM0sDZHTtTbnG31IoAoSDHBqONfmwDgmppgevXjimIDnjr7jNAFmHBArSiHzAfQVnw8Yq/FjzB/OgCXHJPX0rPkJSYg/c61dJ+bjtWdfuF2nOGBx+FADNR2PAe2OSf6VyWqR/LuVRs/WumdlliIzntzWJeQoGZGOfcUAcpNvc9gOfwqg7TMflXoerVrXxSCQiVDnJxVSI/aJBGwYIP4hQBnwWd3PdOSo29evWtuwhjDKXQNt49amEkMeyFJAoPUnqat2kcMJ3fLsPVh6UARSrCjFiBheelQPcwoxlK5GOBjpxWJrV8WuCsPyKOqnGTVP7eluBG+WD4Bx2oA2XvZDCswA8xvurjjNUbi6muEL3cYDSHGAarJe+bL5RbheV6ECopoWN6XkyWXpk0ARyb7LURKEKrkFSfwr1q0u5JIV2qpfHBbp+NeUeIJZDcxRKD2yMcCvTdLk326ttI4zigDcguDv27RknBxU5XJy3AqlGu3DEHrxVwYYBSvWgCS3VYxsXLY5JNWwOOBUCYBwB0FTICRycDtQA8LxzTwABTVHHBzihulACEjt/KheopDjjijd0xQA9ueB60oHPqKN3y0KQPxoAaeBntQe2ccU4sPxqN2AHNAEcpBGKeiA8n/wDXVcsxOPSplZSCOnFACPCQxIY49McCnMu8YPenRt1BINIxCsKAKjwgDCqAahZCoO44B6VoMc81Wnj3H/CgCi0CuNrAEeprltf0HrNp8cYkHVNuA1dcVw20nigwo2OefSgDy8LGFCyDZN0MZ7Gr2mny3AbOOep9q2vEOhxXBZ1Qq/VSPp3rnbfzYJil0hBHFAG8bNmYNEPlPXHpWxZLiMnGPWqVipjgB6/rWnD80QOMN6UAaWnvuDIO1TTL8nA471SsW2kZBz0/Wr0nQjFAFOQYx+WKbD1p8gBWki5xgcUATQHpVyOVEkQPIqs5wik8sevH4VThxt96vQgZBIBPr6UANkYDPNZt0N7FWPysOKs3z7ZMKcDNVJslQRnj070AZ/mGJtpHAqlfsWcuTzjoO9X51Zn+XHI5NVZESJCCSx55NAGTcaclyheVxuAJA9KxrpgkoihGBnGe1bc6PKdu7HJyKxtUiKsEToR170AZt1810pZ8t0AFbH2jybRQ3zPjoKZY6aGiLu+0IOrEY61T1G5ihRtjBtvv1Oe1AGXLGJJw4785qpeBBIwUjzcYFadov2iJpMiOIDO4+tZMUZlulYsCckk0AP061EZSSc8dcVdu457mdGjwkXGM9SKv20UMkPmuS2zt+FNu7kn/AFAC7eDnvQBJdRJN5boMXG4Dr16V3GmK6Wal+uK89s7oPco0zr5gbITPNd5BeyiLzHjjEfAJViSBnr0oA27ZhJHjovarsWAoywFYlnKxYYfcuc/hWoWDbAMAUAXerZ6VKDzjPv1qrE+Dgn/61WBwM8UASrnFAI9MGmDjmlzzk4oARiNx96M4xzQx44AxTQxDKR0zQBICe1AJz2pA2fSjoM0ABP0qCVgcDP606onOfr70AAPOKkDcHBFQqflJ59KehyvWgB6HByDSyNyM1HnBBpzH5s5xjvQA4HsTxTWyG74puSSOnNOPIINAEMkYOT0qMLyM9qsAgfSkIGRgUAVLtdyDgmsa/wBOjuF+fO5eQRXRugAyelV5EU5xxQBgQoY/3Q+6M5q8jHj2qLUlaJjJHyAOajhmDbXDZDdRmgDYgHy9eR6VbVsr+hqjbScYz+tW4znqeRQBDLkBgaSAAmnStz7Gi39qAFjbrnNX4QCF/A1nRn5fbPFaER+X6CgDO1Bj5m4d6ig+bIPA96mvEzIDjjpUCFVBByPegCKbARhjmsefOGJJAU8+v4Vq3Tqv3uh6D1rOuiApc4UDqKAMm9vGSNgoxnvnms1SJmjYuXx0FTX0bSMzBm+cnAA7VmzyrZooj/1hzuzQBO983mNCSdmfU4NZM0DTzkYCr0+btzTIZmkcvIdq9A3pWhB++ztBCZ/E0ALeKfsCwo2IeOemTWZGgRwiRk543Crl7cCXy4k5C8Bahtp1tjhlEjehoAtqfLBjZsA4x7nFUNYuGgljRflGepPJqOaR7i/jCsFI5JzjpVS/+eV/MfdIOhoAfph/0tZGVjknGeSa9Q02ZPsyLxuPQZrz2DZamP5QFPIPPWuy01xJgkjI6Ad6AOgtVCyD3rQQ44zx3rOtSSPQ+laEPQelAE6+uDyKuoMAd6qRcEDqPpVmLI70AS4pD1560hyMf0FBB9qAA/nTOMilIwOTTeMjkkk0APHfil65x0oHTjrSZ4/xoAjk5qJugFSOSW5pD2NADOablhIABlecknpT880gGScfnQA8e4+lMkPPFSAcZ70x+f8A9VADNxwOtOPK0YwMc80q8oc0AMBNP3DHOM1ESS5GCMd/Wmh+cUAS7zmophxxRuBxg0pIbPpQBUmXKlWFYsSmG5kU/dJ4rdl2ngjnsaqTxLwQBmgBttKBwc8mtOB+R6GsmQ7RVuwk3EKTyOme9AFuXqe3NEAG7HUUT8ZJOBikteeRzQAsZ6c1cU/I2Koxn5l+tW4iNp7CgCK6xtOKzMgjDHFaNw3TH0rFuX2EqO3T3oANRdUUNu5zismdt8TMxJzxip2SSV8EFie3ari6PLLFhiFGOwoA47Urx4I2ClQuTj1xXPySGVUYlnYk8AZr1SDwvaByZY/N4/iGcmtW20aztgvl20K+mIwMUAeSWulXksQY2twwzwojbmrlrp2poxYWNwPYoRXrogGAAowKesCYwAPyoA8RfTdSi3ymymDDkjYeKzLlLqGRna1nGenyHFfQX2WLGCinPtTGsbYn/UxkD1UUAfOZuSjrI/Eg4IxTAQ9zLJn39q+hJ9F0y4P76wtZO/zQqf6Vlaj4H0W+t5PKtUtpCCA0Khce+KAPFrnURKBETgYwDz1rpfDl8cxqzE4G38adrfwv1C2Jk0ucXeedrAIR+Zqn4e0O+0u9CX8DISe+DyD7GgD02yw0cQPBbrmtZYRjg5rO0yNnhjJ2kjjpWrFkArjAoAlVemDUqcd6j6cUoPI70ATkjGBSdqQHjnrQT+vrQAjDimd+1SdAciozkN+NADhmlHPWkH3hwKd3wRQBGRk9DTTHkgnOR0qTBBqN2yRQAmOcGm4xmkY8kkUoOKAHjp3ppORzSbhnPNJuz0/SgA9wc0m4g0D+VNY88igBV5Y5wPwqKYEHpTt2CMCkL98fpQBEp7Y70E4YkdBSMpzxTT1yQeO1AD3AYBgOfaq8w3CplOQQOlV7htuT3xwKAKsm7AHcUttIwmTqRmmh8thhToxiUcUAa7EkA0W/DY4qOMloh6jpUtv97jBoAii4dc1bJAj5XPOemaowcY5yfWrbH93xQBBdNgZFYzWsl1Nv5CdDWsiCeTDdqupGm0cUAU7WzSMKCBn3rQCgHAFIAMcDpTx3oAVeBwKdnPX8ajz82D0p2eOetAEgGe1OXtxyKYG4GKeOAfUUAGfahj2HApOM/SkoATGaeueQBxSfTqKdnj68UANK4HIFVruyhnGZI03DkHFW89zTCMnd3oAzPJ8lSI1AHpikGcHOc1oSKOc9KqyIACaAI1Y56/hViM4OTVRVB5/GrIOFHoOKALQOetL3PFRqeKdnvQAMM5OPemdCKGJpoPI9aAH0/OaizyKfnvzQAjnj37VCW64FPbGckfSoyw4zn8KAG7iaC+Onemsdufamb6AJWOCPpTAdppo+Y08R89etACNIM8kYpGfI4p5iU9ecU5YUHrQBX3DvTd2WwPzq15aAHimmMA9BmgCo0mDgmh2A+lWHjXHPNNMSlenegCqXAOAaiuZAV6DjpVt4UIPFUri3wp2tyPWgCpw0pIbGO2KtWyknI69Kz3cxyc4znnFXrbbkE9T6UAX4DxirUAwCQoyefrVCE4z7+lXrZF+Ykct1I4zQB//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows mosaic oligemia with localization of pulmonary blood flow to the lower lobes. This may be regarded as a Westermark's sign with oligemia affecting the subtended pulmonary parenchyma of the upper lobes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18964=[""].join("\n");
var outline_f18_33_18964=null;
var title_f18_33_18965="Betaxolol (systemic): Patient drug information";
var content_f18_33_18965=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Betaxolol (systemic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/24/37255?source=see_link\">",
"     see \"Betaxolol (systemic): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7995913\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Kerlone&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10030216\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700256",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not stop taking this drug all of a sudden. If you do, chest pain that is worse and in some cases heart attack may occur. The risk may be greater if you have certain types of heart disease. To avoid side effects, you will want to slowly stop this drug  as ordered by your doctor. Call your doctor right away if you have new or worse chest pain or if other heart problems occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10030218\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10030217\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701621",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to betaxolol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Very weak heart or slow heartbeat without a working pacemaker.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 12 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10030222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697043",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may hide the signs of low blood sugar. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697300",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have lung disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697307",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697343",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have thyroid disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10030223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697963",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in sex ability.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10030225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10030220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10030221\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10030226\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699319",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect tablets from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10030227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11159 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.1.191.153-863D5741FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18965=[""].join("\n");
var outline_f18_33_18965=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7995913\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030216\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030218\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030217\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030222\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030223\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030225\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030220\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030221\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030226\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10030227\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/53/4950?source=related_link\">",
"      Betaxolol (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?21/14/21732?source=related_link\">",
"      Betaxolol (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/24/37255?source=related_link\">",
"      Betaxolol (systemic): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_33_18966="Trochanteric bursitis";
var content_f18_33_18966=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Trochanteric bursitis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18966/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18966/contributors\">",
"     Bruce C Anderson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18966/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18966/contributors\">",
"     Zacharia Isaac, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18966/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18966/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/33/18966/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 5, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inflammation of the trochanteric bursa is one of the most common causes of hip pain [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=see_link\">",
"     \"Evaluation of the adult with hip pain\"",
"    </a>",
"    .) Inflammation occurs in the lubricating sac located between the midpoint of the trochanteric process of the femur and the gluteus medius",
"    <span class=\"nowrap\">",
"     tendon/iliotibial",
"    </span>",
"    tract (",
"    <a class=\"graphic graphic_figure graphicRef60606 \" href=\"UTD.htm?8/53/9042\">",
"     figure 1",
"    </a>",
"    ). A deeper bursal sac, located between the top of the superior trochanteric process and the gluteus medius tendon, can also become inflamed; this is referred to as deep trochanteric bursitis or gluteus medius bursitis. The symptoms, presentation, and treatment of bursitis in either location are virtually identical and, for the purposes of this review, will be referred to simply as trochanteric bursitis unless otherwise noted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trochanteric bursitis is caused by an exaggerated movement of the gluteus medius tendon and the tensor fascia over the outer femur. Repetitive flexing of the hip and direct pressure aggravate the condition. Untreated, the normally paper-thin bursal wall thickens, fibroses, and gradually loses its ability to lubricate the outer hip.",
"   </p>",
"   <p>",
"    A disturbance in gait causes the vast majority of cases of trochanteric bursitis; even subtle gait impairment can increase friction and pressure over the trochanteric process. Common gait abnormalities that may result in trochanteric bursitis include lumbosacral spine disease (75 percent), leg length discrepancy (10 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/2\">",
"     2",
"    </a>",
"    ], sacroiliac joint disorders (5 percent), knee arthritis, and ankle sprain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients typically complain of lateral hip pain over the outer thigh or of difficulty with walking. The hip pain is usually aggravated by direct pressure; depending upon the degree of inflammation and swelling, pressure sensitivity ranges from mild morning pain and stiffness to intolerance to sleeping on the affected side. Patients may rub the thigh when describing the pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of uncomplicated trochanteric bursitis is based upon the following clinical findings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Outer thigh pain",
"     </li>",
"     <li>",
"      Local tenderness",
"     </li>",
"     <li>",
"      Pain relief with regional anesthetic block, which is especially important when radiculopathy is concurrent, when local signs and symptoms are atypical, when there is a dramatic gait disturbance, or when the patient presents with severe pain",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each patient is examined for the degree of local tenderness at the greater trochanter and hip rotation, and an assessment is made of gait, lower back flexibility, and the degree of involvement of the sacroiliac joint.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Local tenderness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpation of both the superficial and deep trochanteric bursa should be performed (",
"    <a class=\"graphic graphic_picture graphicRef58500 \" href=\"UTD.htm?14/48/15104\">",
"     picture 1",
"    </a>",
"    ). Palpation is best performed in the lateral decubitus position with the hip flexed to 90 degrees, optimally exposing the superior aspect of the trochanteric process. The trochanteric process is the most prominent portion of the femur.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inflammation of the superficial bursa is associated with local tenderness at the midportion of the greater trochanter; the point of maximal tenderness is 1.5 inches below the superior portion of the trochanter, directly over the maximum lateral prominence.",
"     </li>",
"     <li>",
"      Inflammation of the deep bursa is associated with local tenderness just superior to the trochanteric process, directly in the midline.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bursitis is the most common cause of trochanteric tenderness. However, tenderness is also seen with occult fracture, with stress fracture, with metastatic disease of the femur, and with the uncommon gluteus medius tendon tears.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Hip rotation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Internal and external rotation are measured to assess the integrity of the hip joint and to evaluate for pain and stiffness (",
"    <a class=\"graphic graphic_picture graphicRef74743 \" href=\"UTD.htm?40/0/40960\">",
"     picture 2",
"    </a>",
"    ). Stiffness or mild discomfort may be experienced at the extremes of internal or external rotation of the hip, although this finding is not as specific as the presence of local tenderness. More severe discomfort or significant limitation in range of motion suggests involvement of the hip joint itself (eg, osteoarthritis or acute synovitis). In general, the range of motion of the hip is normal in uncomplicated trochanteric bursitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Gait",
"    </span>",
"    &nbsp;&mdash;&nbsp;The objective of observing the patient&rsquo;s gait is to assess the impact of the patient&rsquo;s hip condition on his or her overall mobility by observing the ability to perform simple movements. The patient is asked to walk in the examination room; the maneuver is enhanced by asking the patient to toe-and-heel walk.",
"   </p>",
"   <p>",
"    Most cases of bursitis have only a minimal impact upon ambulation. Certain gait patterns may nevertheless be seen in patients with bursitis:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An antalgic gait is a nonspecific finding in patients with hip complaints. The patient with an antalgic gait spends a shorter time weight-bearing on the affected side because of pain.",
"     </li>",
"     <li>",
"      Patients with leg length discrepancy predisposing to bursitis may have a short-leg limp, which is characterized by an increase in the up and down movement of the head and shoulders as the body falls onto the short leg and then rises up on the long leg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain radiographs of the hip are recommended in all patients with suspected trochanteric bursitis, usually including posterior to anterior (PA), lateral, and frog-leg views, to exclude other causes of hip pain. Occasionally, calcifications may be seen in the region of the bursa or adjacent soft tissue.",
"   </p>",
"   <p>",
"    Additional imaging is not required for diagnosis but may be helpful in identifying an underlying cause such as leg length discrepancy. In patients suspected of leg length discrepancy based upon physical examination, a standing anterior to posterior (AP) radiograph of the pelvis should be obtained. In patients suspected of underlying back, sacroiliac, or hip disease, other studies may be required as clinically indicated. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=see_link\">",
"     \"Evaluation of the adult with hip pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25210?source=see_link&amp;anchor=H24#H24\">",
"     \"Radiologic evaluation of the painful hip in adults\", section on 'Greater trochanteric pain syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    More specialized radiography, such as magnetic resonance imaging (MRI), is used only in cases with suspected underlying conditions at the lumbosacral spine, the sacroiliac joint, the femur, or the pelvic bones. MRI also demonstrates increased signal in the bursa of patients with bursitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Regional anesthetic block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Regional anesthetic block may be very helpful in differentiating the pain of trochanteric bursitis from that of referred pain from the lumbosacral spin or from the dysesthetic pain of meralgia paresthetica (",
"    <a class=\"graphic graphic_picture graphicRef54728 \" href=\"UTD.htm?36/22/37217\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef57328 \" href=\"UTD.htm?23/55/24436\">",
"     picture 4",
"    </a>",
"    ). Relief of pain with the injection is consistent with a diagnosis of bursitis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goals of treatment are to reduce inflammation in the bursa, to correct any underlying gait disturbance, and to prevent recurrent bursitis by proper hip and back stretching exercises [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Acute therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heat treatments and passive stretching exercises are used in the first few weeks to reduce the pressure over the bursal sac.",
"   </p>",
"   <p>",
"    Heat is applied to the outer thigh for 15 to 20 minutes to prepare the area for stretching. While in the sitting position, cross-leg pulls are performed in sets of 20 repetitions to reduce the pressure over the bursa. The set of exercises is performed once daily initially and may be increased to twice daily as tolerated.",
"   </p>",
"   <p>",
"    To perform cross-leg pulls, the affected leg is crossed over the other leg while sitting with the spine in a neutral position either in a chair or on the floor. The knee on the affected side is grasped, and the leg should be pulled to the opposite side. The buttocks should be kept flat, and the patient should not roll the pelvis, as the maximum amount of stretch is obtained when both ischial tuberosities of the buttocks are kept flat on a hard surface. A gentle pulling sensation should be felt in the outer buttocks or hip area. After a brief rest, the maneuver should be repeated 20 times.",
"   </p>",
"   <p>",
"    Cross-leg pulls are followed by low back and sacroiliac stretches, of which a set of each is also initially performed once daily. To enhance the flexibility of the lower lumbosacral spine, knee-chest pulls (first pulling one knee up to the chest followed by the other and finally lying flat and gently pulling up the knees to the chest) and side bends (standing straight and bending to the right then to the left) are each performed in sets of 20 repetitions. The pelvic rock exercise provides increased flexibility to the sacroiliac joint (on all fours the pelvis is gently rotated forward and backwards). Sets of 20 repetitions of the sacroiliac exercise are performed after the lower back stretches. Stretching these areas increases flexibility of the lower spine, the sacroiliac joints, and the hips. Therapeutic ultrasound provides deep heating to the area and can be combined with stretching exercises.",
"   </p>",
"   <p>",
"    Daily stretching exercises may be cut back to three times a week once local symptoms have resolved.",
"   </p>",
"   <p>",
"    Other measures that should be performed in the acute setting include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A nonsteroidal antiinflammatory drug (NSAID) can be prescribed at full dose for the first four weeks.",
"     </li>",
"     <li>",
"      Correct any underlying gait disturbance (eg, a shoe lift for leg length discrepancy, low back stretching exercises, a knee brace, high-top shoes for ankle support, custom-made foot orthotics for ankle pronation).",
"     </li>",
"     <li>",
"      Reduce weightbearing (eg, a lean bar, sitting rather than standing, temporary crutches, weight loss for recurrent cases).",
"     </li>",
"     <li>",
"      Restrict repetitious bending (eg, climbing stairs, getting out of a chair).",
"     </li>",
"     <li>",
"      Avoid direct pressure on the bursa.",
"     </li>",
"     <li>",
"      Suggest sitting with the leg moderately abducted and externally rotated to lessen the pressure over the bursa.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Persistent symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with symptoms persisting for six to eight weeks despite the above measures should be reevaluated for an underlying cause (eg, by use of computerized tomography [CT] or MRI of the low back or by bone scan). The specific studies depend upon whether and which alternative diagnoses are being considered. CT or MRI of the lumbosacral spine may be required in patients with abnormal radiographs or radiculopathy. Nuclear bone scans may be obtained to exclude occult fractures of the pelvis and femur and to exclude metastatic lesions in a patient with known solid tumors. Ultrasonography is helpful in indentifying gluteus medius tendon tears. If not performed already, a standing AP pelvis film should be performed at this time to evaluate for leg length discrepancy.",
"   </p>",
"   <p>",
"    In the absence of an underlying correctable cause of bursitis, local injection of the bursa can be performed in patients that have failed the conservative care noted above. Patients with severe pain at presentation, especially pain interfering dramatically with sleep and daily activities, can be treated earlier.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Injection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uncomplicated bursitis (eg, not associated with an underlying gait disturbance) responds favorably to local glucocorticoid injection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/4-7\">",
"     4-7",
"    </a>",
"    ]. In one study of patients with trochanteric bursitis, for example, rapid and prolonged improvement of the associated pain and disability was achieved in all 65 of those treated by local glucocorticoid and anesthetic injection (48 patients after one, 13 patients after two, and four patients after three injections) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/4\">",
"     4",
"    </a>",
"    ]. A second study achieved similar results, although one-quarter relapsed in two years [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/5\">",
"     5",
"    </a>",
"    ]. Higher doses of glucocorticoids may be associated with greater symptom relief [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30951?source=see_link\">",
"     \"Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The success of injection depends upon accurate injection of the bursa at the level of the femur (",
"    <a class=\"graphic graphic_picture graphicRef54728 \" href=\"UTD.htm?36/22/37217\">",
"     picture 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef57328 \" href=\"UTD.htm?23/55/24436\">",
"     picture 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient is placed in the lateral decubitus position with the affected side up and with the knees flexed to 90 degrees (the trochanter is most prominent in this position).",
"     </li>",
"     <li>",
"      The superior, posterior, and anterior edges of the trochanteric process are palpated and marked. The point of entry for injection of the superficial bursa is directly over the center point of the trochanter, 1.5 inches below the superior trochanter. Alternatively, the point of entry is at the crown of the trochanter viewed tangentially. For injection of the deep bursa, the point of entry is 0.75 to 1 inch above the midpoint of the most superior portion of the trochanter.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?14/2/14370?source=see_link\">",
"       Ethyl chloride",
"      </a>",
"      is sprayed on the skin. Local anesthetic is placed at the gluteus medius tissue plane (1 mL) and at the periosteum of the femur (0.5 to 1 mL).",
"     </li>",
"     <li>",
"      For superficial bursal injection, the needle is inserted perpendicular to the skin; the depth is 1.5 to 3 inches to the femur. For deep bursal injection, the needle is inserted at a 45&ordm; angle in direct alignment with the femur; the depth is 1 to 2.5 inches to the gluteus medius tendon and 1.5 to 3 inches to the superior trochanter.",
"     </li>",
"     <li>",
"      The needle is held very lightly and is advanced through the low resistance of the subcutaneous fat to the firm, rubbery resistance of the gluteus medius tissue plane. Following anesthesia at this level, the needle is advanced with firm pressure",
"      <span class=\"nowrap\">",
"       1/2",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       5/8",
"      </span>",
"      inches farther to the periosteum of the femur. The patient will usually experience sharp pain as the needle touches the periosteum. Injection at this deeper level requires firm pressure. The needle should be rotated 180 degrees or should be withdrawn slightly if excessive pressure is encountered. If the trochanter tenderness is significantly relieved with anesthetic injection, 1 mL of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/38/39520?source=see_link\">",
"       triamcinolone",
"      </a>",
"      acetonide 40",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      is injected through the same needle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Injection aftercare",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injection aftercare is",
"    <strong>",
"     critical",
"    </strong>",
"    to the success of glucocorticoid injections. The patient should be advised to:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rest for three days, avoiding direct pressure and repetitive bending. Moderation of activity is adequate for most patients. For those patients with severe local pain and tenderness, with recurrent or chronic symptoms, or with dramatic impairment of gait, three days of complete bedrest and crutches (with touch-down weightbearing) are advised.",
"     </li>",
"     <li>",
"      Use ice (15 minutes every four to six hours) and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      (1000 mg twice a day) for soreness.",
"     </li>",
"     <li>",
"      Protect the hip for three to four weeks by limiting direct pressure, repetitive bending, prolonged standing, and unnecessary walking.",
"     </li>",
"     <li>",
"      Begin cross-leg stretching exercises for the gluteus medius on day four.",
"     </li>",
"     <li>",
"      For patients with accompanying structural back disease, begin flexion stretching exercises of the low back after the acute pain has begun to resolve.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The injection may be repeated in six weeks if pain persists.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Chronic cases",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with symptoms persisting despite the above may benefit from a more thorough search for or treatment of underlying gait disturbances if not already done. Deep ultrasound can also be helpful in some instances. In our experience, a transcutaneous electrical nerve stimulation (TENS) unit may be helpful in patients with chronic bursitis due to structural back disease or to chronic neurologic impairment.",
"   </p>",
"   <p>",
"    Patients with chronic symptoms resistant to other treatments and with significant leg length discrepancy (eg, from scoliosis, fused joints, or a major length shortening fracture of the femur or tibia) should be referred to a physiatrist or an orthopaedic surgeon for further evaluation and treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is rarely performed for this condition, although it should be considered in patients in whom conservative treatment and at least two separate consecutive injections over two months have failed and in whom refractory symptoms have been present for more than one year. Patients with morbid obesity, diabetes, and a dramatic gait disturbance are at the greatest risk for refractory and recurrent bursitis and may benefit from a definitive procedure. Surgical approaches include longitudinal release of the iliotibial band over the greater trochanter [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]; distal lengthening of the iliotibial band by Z-plasty, which can be performed as an outpatient procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/10\">",
"     10",
"    </a>",
"    ]; and excision of the subgluteal bursa [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18966/abstract/11\">",
"     11",
"    </a>",
"    ]. The bursa probably reforms after bursectomy, however, if lateral hip friction and pressure persist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/23/3443?source=see_link\">",
"       \"Patient information: Bursitis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?23/46/24289?source=see_link\">",
"       \"Patient information: Hip pain (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/27/44467?source=see_link\">",
"       \"Patient information: Bursitis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6525711\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trochanteric bursitis, a common cause of hip pain, is caused in most patients by an abnormality in gait that results in exaggerated movement of the gluteus medius tendon and the tensor fascia over the outer femur, causing inflammation in the lubricating sac located between the midpoint of the trochanteric process of the femur and the gluteus medius",
"      <span class=\"nowrap\">",
"       tendon/iliotibial",
"      </span>",
"      tract. Repetitive flexing of the hip and direct pressure aggravate the condition. Deep trochanteric bursitis or gluteus medius bursitis is due to inflammation of a deeper bursal sac, located between the top of the superior trochanteric process and the gluteus medius tendon. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients typically complain of lateral hip pain over the outer thigh or of difficulty with walking. The pain is usually aggravated by direct pressure. Each patient should be examined for the degree of local tenderness at the greater trochanter and hip rotation, and an assessment should be made of gait, lower back flexibility, and the degree of involvement of the sacroiliac joint. The diagnosis of uncomplicated trochanteric bursitis is based upon the findings of outer thigh pain, local tenderness, and pain relief with regional anesthetic block. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Presentation'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bursitis is the most common cause of trochanteric tenderness. However, tenderness is also seen with occult fracture, stress fracture, gluteus medius tendon tears, and metastatic disease of the femur. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Local tenderness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain radiographs of the hip (PA, lateral, and frog-leg views) are recommended in all patients with suspected trochanteric bursitis. Other studies are obtained if further disorders are suspected clinically. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Radiography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Regional anesthetic block may be very helpful in differentiating the pain of trochanteric bursitis from referred pain from the lumbosacral spine or from the dysesthetic pain of meralgia paresthetica. Relief of pain with the injection is consistent with a diagnosis of bursitis. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Regional anesthetic block'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goals of treatment are to reduce inflammation in the bursa, to correct any underlying gait disturbance, and to prevent recurrent bursitis by proper hip and back stretching exercises. Heat treatments and passive stretching exercises are used in the first few weeks to reduce the pressure over the bursal sac. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Acute therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with symptoms persisting for six to eight weeks despite the above measures should be reevaluated for an underlying cause. A standing AP pelvis film should be obtained, if not performed already, to evaluate for leg length discrepancy. In patients with persistent symptoms and in the absence of an underlying correctable cause of bursitis, local injection of the bursa may be of benefit. Injection aftercare is critical to the success of glucocorticoid injections and includes rest, icing, avoidance of strain or injury, and stretching. The injection may be repeated in six weeks if pain persists. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Persistent symptoms'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Injection'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Injection aftercare'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with persistent symptoms may benefit from a more thorough search for or treatment of an underlying gait disturbance if not already done. Deep ultrasound or a TENS unit can also be helpful in some instances. Surgery is rarely performed for this condition. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Chronic cases'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Anderson BC. Office Orthopedics for Primary Care: Diagnosis and Treatment, 2nd, WB Saunders, Philadelphia 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/2\">",
"      Rothenberg RJ. Rheumatic disease aspects of leg length inequality. Semin Arthritis Rheum 1988; 17:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/3\">",
"      Lustenberger DP, Ng VY, Best TM, Ellis TJ. Efficacy of treatment of trochanteric bursitis: a systematic review. Clin J Sport Med 2011; 21:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/4\">",
"      Schapira D, Nahir M, Scharf Y. Trochanteric bursitis: a common clinical problem. Arch Phys Med Rehabil 1986; 67:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/5\">",
"      Ege Rasmussen KJ, Fan&oslash; N. Trochanteric bursitis. Treatment by corticosteroid injection. Scand J Rheumatol 1985; 14:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/6\">",
"      Shbeeb MI, O'Duffy JD, Michet CJ Jr, et al. Evaluation of glucocorticosteroid injection for the treatment of trochanteric bursitis. J Rheumatol 1996; 23:2104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/7\">",
"      Brinks A, van Rijn RM, Willemsen SP, et al. Corticosteroid injections for greater trochanteric pain syndrome: a randomized controlled trial in primary care. Ann Fam Med 2011; 9:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/8\">",
"      Domb BG, Nasser RM, Botser IB. Partial-thickness tears of the gluteus medius: rationale and technique for trans-tendinous endoscopic repair. Arthroscopy 2010; 26:1697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/9\">",
"      Walsh MJ, Walton JR, Walsh NA. Surgical repair of the gluteal tendons: a report of 72 cases. J Arthroplasty 2011; 26:1514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/10\">",
"      Davies H, Zhaeentan S, Tavakkolizadeh A, Janes G. Surgical repair of chronic tears of the hip abductor mechanism. Hip Int 2009; 19:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18966/abstract/11\">",
"      Slawski DP, Howard RF. Surgical management of refractory trochanteric bursitis. Am J Sports Med 1997; 25:86.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7760 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-122.72.76.133-D31E40A6FC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18966=[""].join("\n");
var outline_f18_33_18966=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6525711\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Local tenderness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Hip rotation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Gait",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Regional anesthetic block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Acute therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Persistent symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Injection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Injection aftercare",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Chronic cases",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6525711\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/7760\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7760|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/53/9042\" title=\"figure 1\">",
"      Trochanteric bursa",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/7760|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/48/15104\" title=\"picture 1\">",
"      Palpation trochanteric bursa",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/0/40960\" title=\"picture 2\">",
"      Internal external hip rotation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/22/37217\" title=\"picture 3\">",
"      Injection at mid trochanter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/55/24436\" title=\"picture 4\">",
"      Injection superior trochanter",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/36/22088?source=related_link\">",
"      Evaluation of the adult with hip pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/14/30951?source=related_link\">",
"      Intraarticular and soft tissue injections: What agent(s) to inject and how frequently?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/27/44467?source=related_link\">",
"      Patient information: Bursitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/23/3443?source=related_link\">",
"      Patient information: Bursitis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?23/46/24289?source=related_link\">",
"      Patient information: Hip pain (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/39/25210?source=related_link\">",
"      Radiologic evaluation of the painful hip in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_33_18967="Desvenlafaxine: Drug information";
var content_f18_33_18967=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Desvenlafaxine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?5/57/6038?source=see_link\">",
"    see \"Desvenlafaxine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F6107464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6107466\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Pristiq&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F9831939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Pristiq&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F6107470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidepressant, Serotonin/Norepinephrine Reuptake Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F6107705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Depression:",
"     </b>",
"     Oral: 50 mg once daily; doses up to 400 mg once daily have been studied; however, the manufacturer states there is no evidence that doses &gt;50 mg/day confer any additional benefit. A flat dose response curve for efficacy between 50-400 mg/day has been noted as well as an increase in adverse events.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Gradually taper dose (by increasing dosing interval) if discontinuing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      MAO inhibitor recommendations:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Switching to or from an MAO inhibitor intended to treat psychiatric disorders:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Allow 14 days to elapse between discontinuing an MAO inhibitor intended to treat psychiatric disorders and initiation of desvenlafaxine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Allow 7 days to elapse between discontinuing desvenlafaxine and initiation of an MAO inhibitor intended to treat psychiatric disorders.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Use with other MAO inhibitors (linezolid or I.V. methylene blue):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Do not initiate desvenlafaxine in patients receiving linezolid or I.V. methylene blue; consider other interventions for psychiatric condition.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     If urgent treatment with linezolid or I.V. methylene blue is required in a patient already receiving desvenlafaxine and potential benefits outweigh potential risks, discontinue desvenlafaxine promptly and administer linezolid or I.V. methylene blue. Monitor for SS for 7 days or until 24 hours after the last dose of linezolid or I.V. methylene blue, whichever comes first. May resume desvenlafaxine 24 hours after the last dose of linezolid or I.V. methylene blue.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F6107706\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F6107707\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &gt;50 mL/minute: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     30-50 mL/minute: 50 mg once daily (maximum)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute: 50 mg every other day (maximum)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     End-stage renal disease (ESRD) requiring hemodialysis (HD): 50 mg every other day (maximum). Supplemental doses should not be given after  HD.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F6107708\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mild impairment: No dosage adjustment necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate-to-severe impairment: Initial: 50 mg once daily; maximum dose: 100 mg daily",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F6107717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, extended release, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Pristiq&reg;: 50 mg, 100 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F6107468\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088985.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm088985.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F6107711\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Administer at approximately the same time each day. May be taken with or without food. Swallow tablet whole; do not crush, chew, break, or dissolve. When discontinuing therapy, extend dosing interval to taper.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F6107473\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of major depressive disorder (acute and maintenance)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F13931523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F6107583\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reported for 50-100 mg/day.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Dizziness (10% to 13%), insomnia (9% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Hyperhidrosis (10% to 11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (22% to 26%), xerostomia (11% to 17%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Cardiovascular: Orthostatic hypotension (elderly 8%), syncope (&lt;2%), tachycardia (&lt;2%), hypertension (dose related; &le;1% of patients taking 50-100 mg daily had sustained diastolic BP &ge;90 mm Hg)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Somnolence (&le;9%), fatigue (7%), anxiety (3% to 5%), abnormal dreams (2% to 3%), vertigo (&le;2%), feeling jittery (&le;2%), depersonalization (&lt;2%), seizures (&lt;2%), attention disturbance (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Alopecia (&lt;2%), angioedema (&lt;2%), photosensitivity reaction (&lt;2%), rash (&lt;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Libido decreased (males 4% to 5%), cholesterol (increased by &ge;50 mg/dL and &ge;261 mg/dL: 3% to 4%), anorgasmia (females 1%; males &le;3%), prolactin increased (&lt;2%), hot flushes (1%), low density lipoprotein cholesterol (increased by &ge;50 mg/dL and &ge;190 mg/dL: &le;1%), sexual dysfunction (males &le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Constipation (9%), appetite decreased (5% to 8%), vomiting (&le;4%), weight gain (&lt;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Genitourinary: Urinary retention (&lt;2%), urinary hesitancy (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: Liver function tests abnormal (&lt;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Tremor (&le;3%), dystonia (&lt;2%), stiffness (&lt;2%), weakness (&lt;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ocular: Blurred vision (3% to 4%), mydriasis (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Otic: Tinnitus (&le;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Proteinuria (6% to 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: Ejaculation retarded (1% to 5%), erectile dysfunction (3% to 6%), bruxism (&lt;2%), yawning (1%), ejaculation failure (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Coronary occlusion, myocardial infarction, myocardial ischemia, Stevens-Johnson syndrome",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F6107478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to desvenlafaxine, venlafaxine or any component of the formulation; use of MAO inhibitors intended to treat psychiatric disorders (concurrently or within 14 days of discontinuing the MAO inhibitor); initiation of MAO inhibitor intended to treat psychiatric disorders within 7 days of discontinuing desvenlafaxine; initiation of desvenlafaxine in a patient receiving linezolid or intravenous methylene blue",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F6107479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Major psychiatric warnings:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal thinking/behavior:",
"     <b>",
"      [U.S. Boxed Warning]: Antidepressants increase the risk of suicidal thinking and behavior in children, adolescents, and young adults (18-24 years of age) with major depressive disorder (MDD) and other psychiatric disorders;",
"     </b>",
"     consider risk prior to prescribing. Short-term studies did not show an increased risk in patients &gt;24 years of age and showed a decreased risk in patients &ge;65 years. Closely monitor for clinical worsening, suicidality, or unusual changes in behavior; the patient&rsquo;s family or caregiver should be instructed to closely observe the patient and communicate condition with healthcare provider. A medication guide concerning the use of antidepressants in children and teenagers should be dispensed with each prescription.",
"     <b>",
"      Desvenlafaxine is not FDA approved for use in children.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; The possibility of a suicide attempt is inherent in major depression and may persist until remission occurs. Patients treated with antidepressants should be observed for clinical worsening and suicidality, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases. Worsening depression and severe abrupt suicidality that are not part of the presenting symptoms may require discontinuation or modification of drug therapy. Use caution in high-risk patients during initiation of therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prescriptions should be written for the smallest quantity consistent with good patient care. The patient's family or caregiver should be alerted to monitor patients for the emergence of suicidality and associated behaviors such as anxiety, agitation, panic attacks, insomnia, irritability, hostility, impulsivity, akathisia, hypomania, and mania; patients should be instructed to notify their healthcare provider if any of these symptoms or worsening depression or psychosis occur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anxiety/insomnia: May cause increase in anxiety, nervousness, and insomnia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bleeding risk: May impair platelet aggregation resulting in increased risk of bleeding events, particularly if used concomitantly with aspirin or NSAIDs due to ulcerogenic potential. Data are inconclusive regarding extent of bleeding risk of SNRIs in combination with warfarin or other anticoagulants. Bleeding related to SNRI use has been reported to range from relatively minor bruising and epistaxis to life-threatening hemorrhage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; CNS depression: Has a low potential to impair cognitive or motor performance; caution operating hazardous machinery or driving.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dyslipidemia: May cause significant dose-related increases in total cholesterol, LDL, and triglycerides; monitor.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertension: Dose-related increases in systolic and diastolic blood pressure have been documented. Monitor blood pressure regularly, and if sustained increases noted, consider dose reduction or discontinuation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pulmonary events: Interstitial lung disease and eosinophilic pneumonia have been rarely reported with venlafaxine (the parent drug of desvenlafaxine). May present as progressive dyspnea, cough, and/or chest pain. Prompt evaluation and possible discontinuation of therapy may be necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Serotonin syndrome: Potentially life-threatening serotonin syndrome (SS) has occurred with serotonergic agents (eg, SSRIs, SNRIs), particularly when used in combination with other serotonergic agents (eg, triptans, TCAs, fentanyl, lithium, tramadol, buspirone, St John&rsquo;s wort, tryptophan) or agents that impair metabolism of serotonin (eg, MOA inhibitors intended to treat psychiatric disorders, other MAO inhibitors [ie, linezolid and intravenous methylene blue]). Monitor patients closely for signs of SS such as mental status changes (eg, agitation, hallucinations, delirium, coma); autonomic instability (eg, tachycardia, labile blood pressure, diaphoresis); neuromuscular changes (eg, tremor, rigidity, myoclonus); GI symptoms (eg, nausea, vomiting, diarrhea); and/or seizures. Discontinue treatment (and any concomitant serotonergic agent) immediately if signs/symptoms arise.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sexual dysfunction: May cause or exacerbate sexual dysfunction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; SIADH and hyponatremia: SSRIs and SNRIs have been associated with the development of SIADH; hyponatremia has been reported rarely (including severe cases with serum sodium &lt;110 mmol/L). Age (the elderly), volume depletion and/or concurrent use of diuretics likely increases risk. Discontinue treatment in patients with symptomatic hyponatremia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: May cause sustained increase in blood pressure or heart rate. Control pre-existing hypertension prior to initiation of desvenlafaxine. Use caution in patients with recent history of MI, unstable heart disease, or cerebrovascular disease. Hypertensive effect is dose related.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use caution; clearance is decreased and average AUC is increased; dosage adjustment recommended in patients with hepatic impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Mania/hypomania: May worsen psychosis in some patients or precipitate a shift to mania or hypomania in patients with bipolar disorder. Monotherapy in patients with bipolar disorder should be avoided. Patients presenting with depressive symptoms should be screened for bipolar disorder.",
"     <b>",
"      Desvenlafaxine is not FDA approved for the treatment of bipolar depression.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Narrow-angle glaucoma: May cause mydriasis; use caution in patients with increased intraocular pressure or at risk of acute narrow-angle glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use caution; clearance is decreased and plasma concentrations are increased; dosage reduction recommended in patients with severe renal impairment or end-stage renal disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorders: Use caution in patients with a previous seizure disorder.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use caution in elderly patients; may cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; monitor sodium closely with initiation or dosage adjustments in older adults (Beers Criteria). In addition, the elderly are at increased risk for orthostatic hypotension with therapy compared to younger adults.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Withdrawal syndrome: Abrupt discontinuation or dosage reduction has been associated with a wide range of reactions, including (but not limited to) dysphoric mood, irritability, agitation, dizziness, sensory disturbances (eg, electric shock-like sensations), anxiety, confusion, impaired coordination/balance, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures. Discontinuation symptoms may also occur when switching from another antidepressant.  When discontinuing therapy or switching antidepressants, gradually taper dose. If intolerable symptoms occur following a decrease in dosage or upon discontinuation of therapy, then resuming the previous dose with a more gradual taper should be considered.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F6107644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2D6 (weak);",
"     <b>",
"      Induces",
"     </b>",
"     CYP3A4 (weak/moderate)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6107643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the adverse/toxic effect of Serotonin/Norepinephrine Reuptake Inhibitors. Specifically, risks of psychomotor impairment may be enhanced. Alcohol (Ethyl) may enhance the hepatotoxic effect of Serotonin/Norepinephrine Reuptake Inhibitors. Particularly duloxetine and milnacipran. Management: Patients receiving serotonin/norepinephrine reuptake inhibitors (SNRIs) should be advised to avoid alcohol.  Monitor for increased psychomotor impairment and hepatotoxicity in patients who consume alcohol during treatment with SNRIs.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha-/Beta-Agonists: Serotonin/Norepinephrine Reuptake Inhibitors may enhance the tachycardic effect of Alpha-/Beta-Agonists. Serotonin/Norepinephrine Reuptake Inhibitors may enhance the vasopressor effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha2-Agonists: Serotonin/Norepinephrine Reuptake Inhibitors may diminish the antihypertensive effect of Alpha2-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Apraclonidine; Brimonidine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antipsychotics: May enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aspirin: Serotonin/Norepinephrine Reuptake Inhibitors may enhance the antiplatelet effect of Aspirin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Axitinib: CYP3A4 Inducers (Weakly to Moderately Effective) may decrease the serum concentration of Axitinib.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Serotonin/Norepinephrine Reuptake Inhibitors may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ioflupane I 123: Serotonin/Norepinephrine Reuptake Inhibitors may diminish the diagnostic effect of Ioflupane I 123.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the serotonergic effect of Serotonin/Norepinephrine Reuptake Inhibitors. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the serotonergic effect of Serotonin/Norepinephrine Reuptake Inhibitors. This may cause serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylene Blue: Serotonin/Norepinephrine Reuptake Inhibitors may enhance the serotonergic effect of Methylene Blue. This could result in serotonin syndrome.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: Serotonin Modulators may enhance the adverse/toxic effect of Metoclopramide. This may be manifest as symptoms consistent with serotonin syndrome or neuroleptic malignant syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     NSAID (Nonselective): Serotonin/Norepinephrine Reuptake Inhibitors may enhance the antiplatelet effect of NSAID (Nonselective).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Saxagliptin: CYP3A4 Inducers may decrease the serum concentration of Saxagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: May enhance the adverse/toxic effect of other Serotonin Modulators. The development of serotonin syndrome may occur.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Desvenlafaxine may enhance the adverse/toxic effect of Vitamin K Antagonists. Specifically, the risk for bleeding may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F6107646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: Avoid St John's wort,  tryptophan (may increase risk of serotonin syndrome and/or excessive sedation).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F6107474\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6107475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have been observed in some animal reproduction studies. Nonteratogenic effects in the newborn following SSRI/SNRI exposure late in the third trimester include respiratory distress, cyanosis, apnea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycemia, hyper- or hypotonia, hyper-reflexia, jitteriness, irritability, constant crying, and tremor. Symptoms may be due to the toxicity of the SNRIs/SSRIs or a discontinuation syndrome and may be consistent with serotonin syndrome associated with treatment. The long-term effects of",
"     <i>",
"      in utero",
"     </i>",
"     SNRI/SSRI exposure on infant development and behavior are not known.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     The ACOG recommends that therapy with SSRIs or SNRIs during pregnancy be individualized; treatment of depression during pregnancy should incorporate the clinical expertise of the mental health clinician, obstetrician, primary healthcare provider, and pediatrician. According to the American Psychiatric Association (APA), the risks of medication treatment should be weighed against other treatment options and untreated depression. For women who discontinue antidepressant medications during pregnancy and who may be at high risk for postpartum depression, the medications can be restarted following delivery. Treatment algorithms have been developed by the ACOG and the APA for the management of depression in women prior to conception and during pregnancy.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Desvenlafaxine is the major active metabolite of venlafaxine; also refer to the Venlafaxine monograph.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F6107476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F6107477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Desvenlafaxine is excreted in human milk and can be detected in the serum of nursing infants. The manufacturer recommends breast-feeding during therapy only if the expected benefits to the mother outweigh any potential risk to the infant.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F6107710\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F6133125\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, 24-hour",
"     </b>",
"     (Pristiq Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (14): $90.46",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (14): $90.46",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F6107713\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Renal function for dosing purposes; blood pressure should be regularly monitored, especially in patients with a high baseline blood pressure; lipid panel (eg, total cholesterol, LDL, triglycerides); signs/symptoms of serotonin syndrome; mental status for depression, suicide ideation (especially at the beginning of therapy or when doses are increased or decreased). Intraocular pressure should be monitored in those with baseline elevations or a history of glaucoma.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Pristiq (AU, BR, CN, CO, CR, EC, GT, HK, HN, MY, NI, PA, PH, SG, SV, TH);",
"     </li>",
"     <li>",
"      Zyven-OD (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F6107647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Desvenlafaxine is a potent and selective serotonin and norepinephrine reuptake inhibitor.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F6107649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 3.4 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hepatic via conjugation (major pathway), and oxidation via CYP3A4 (minor pathway)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: ~80%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: ~10-11 hours; prolonged in renal failure and hepatic failure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (45% as unchanged drug; ~24% as metabolites)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American College of Obstetricians and Gynecologists, ACOG Practice Bulletin: Clinical Management Guidelines for Obstetricians-Gynecologists No. 92 April 2008 (Replaces Practice Bulletin Number 87, November 2007), &ldquo;Use of Psychiatric Medications During Pregnancy and Lactation,&rdquo;",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2008, 111(4):1001-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/18378767/pubmed\" id=\"18378767\" target=\"_blank\">",
"        18378767",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Psychiatric Association, &ldquo;Practice Guideline for the Treatment of Patients With Major Depressive Disorder,&rdquo; Third Edition, May 2010; file://www.psychiatryonline.com/pracGuide/PracticePDFs/PG_Depression3rdEd.pdf",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Boyer EW and Shannon M, &ldquo;The Serotonin Syndrome,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2005, 352(11):1112-20.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/15784664/pubmed\" id=\"15784664\" target=\"_blank\">",
"        15784664",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chambers CD, Hernandez-Diaz S, Van Marter LJ, et al, &ldquo;Selective Serotonin-Reuptake Inhibitors and Risk of Persistent Pulmonary Hypertension of the Newborn,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2006, 354(6):579-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/16467545/pubmed\" id=\"16467545\" target=\"_blank\">",
"        16467545",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DeMartinis NA, Yeung PP, Entsuah R, et al, &ldquo;A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Desvenlafaxine Succinate in the Treatment of Major Depressive Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2007, 68(5):677-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/17503976/pubmed\" id=\"17503976\" target=\"_blank\">",
"        17503976",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dunkley EJ, Isbister GK, Sibbritt D, et al, &ldquo;The Hunter Serotonin Toxicity Criteria: Simple and Accurate Diagnostic Decision Rules for Serotonin Toxicity,&rdquo;",
"      <i>",
"       QJM",
"      </i>",
"      , 2003, 96(9):635-42.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/12925718/pubmed\" id=\"12925718\" target=\"_blank\">",
"        12925718",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liebowitz MR, Yeung PP, and Entsuah R, &ldquo;A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlavaxine Succinate in Adult Outpatients With Major Depressive Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2007, 68(11):1663-72.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/18052559/pubmed\" id=\"18052559\" target=\"_blank\">",
"        18052559",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nelson JC and Devanand DP, \"A Systematic Review and Meta-Analysis of Placebo-Controlled Antidepressant Studies in People With Depression and Dementia,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2011, 59(4):577-85.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/21453380/pubmed\" id=\"21453380\" target=\"_blank\">",
"        21453380",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Septien-Velez L, Pitrosky B, Padmanabhan SK, et al, &ldquo;A Randomized, Double-Blind, Placebo-Controlled Trial of Desvenlafaxine Succinate in The Treatment of Major Depressive Disorder,&rdquo;",
"      <i>",
"       Int Clin Psychopharmacol",
"      </i>",
"      , 2007, 22(6):338-47.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/17917552/pubmed\" id=\"17917552\" target=\"_blank\">",
"        17917552",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stevens DL, &ldquo;Association Between Selective Serotonin-Reuptake Inhibitors, Second-Generation Antipsychotics, and Neuroleptic Malignant Syndrome,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2008, 42(9):1290-7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Use of Psychoactive Medication During Pregnancy and Possible Effects on the Fetus and Newborn. Committee on Drugs. American Academy of Pediatrics,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2000, 105(4 Pt 1):880-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/10742343/pubmed\" id=\"10742343\" target=\"_blank\">",
"        10742343",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Yonkers KA, Wisner KL, Stewart DE, et al, \"The Management of Depression During Pregnancy: A Report From the American Psychiatric Association and the American College of Obstetricians and Gynecologists,\"",
"      <i>",
"       Obstet Gynecol",
"      </i>",
"      , 2009, 114(3):703-13.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?18/33/18967/abstract-text/19701065/pubmed\" id=\"19701065\" target=\"_blank\">",
"        19701065",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8944 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-A20BFA4EA1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18967=[""].join("\n");
var outline_f18_33_18967=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107464\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107466\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F9831939\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107470\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107705\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107706\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107707\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107708\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107717\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107468\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874552\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107711\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107473\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13931523\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107583\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107478\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107479\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107644\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107643\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107646\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107474\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107475\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107476\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107477\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107710\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6133125\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107713\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961937\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107647\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6107649\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8944\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8944|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?5/57/6038?source=related_link\">",
"      Desvenlafaxine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_33_18968="Benefits and risks of smoking cessation";
var content_f18_33_18968=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Benefits and risks of smoking cessation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18968/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18968/contributors\">",
"     Nancy A Rigotti, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18968/contributors\">",
"     Stephen I Rennard, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18968/contributors\">",
"     David M Daughton, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18968/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18968/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18968/contributors\">",
"     Robert H Fletcher, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18968/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18968/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/33/18968/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H87359850\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cigarette smoking is the leading preventable cause of mortality, responsible for nearly six million deaths worldwide and over 400,000 deaths in the United States annually [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. If current trends continue, tobacco will kill more than eight million people worldwide each year by the year 2030. The three major causes of smoking-related mortality are atherosclerotic cardiovascular disease, lung cancer, and chronic obstructive pulmonary disease (COPD) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Smokers who stop smoking reduce their risk of developing and dying from tobacco-related illnesses [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Screening all patients for tobacco use and providing smokers with behavioral counseling and pharmacotherapy to stop smoking are among of the most valuable preventive services that can be offered in health care [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the benefits and risks of smoking cessation. Management of smoking cessation, including the use of behavioral and pharmacologic therapies, is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/13/17626?source=see_link\">",
"     \"Pharmacotherapy for smoking cessation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2589684\">",
"    <span class=\"h1\">",
"     BENEFITS OF SMOKING CESSATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation is associated with substantial health benefits for all smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/7\">",
"     7",
"    </a>",
"    ]. The extent of benefit partly depends on the intensity and duration of prior tobacco smoke exposure. Smokers who stop smoking can be expected to live longer and are less likely to develop tobacco-related diseases, including coronary heart disease, cancer, and pulmonary disease. Smokers also benefit from quitting smoking even after the development of smoking-related diseases, such as coronary heart disease or COPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H64327338\">",
"    <span class=\"h2\">",
"     All-cause mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to one half of all smokers can be expected to die from a tobacco-related illness [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/1\">",
"     1",
"    </a>",
"    ]. In one population-based cohort of nearly 50,000 people aged 40 to 70 years in Norway, the years of life lost were 1.4 years in women and 2.7 years in men among those who smoked &ge;20 cigarettes daily, compared to those who never smoked [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Smoking cessation is associated with a mortality benefit for both men and women of all ages [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/5,8-11\">",
"     5,8-11",
"    </a>",
"    ]. Stopping smoking at younger ages, especially before age 40, is associated with a larger decline in premature mortality than stopping at a later age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/3,8,12\">",
"     3,8,12",
"    </a>",
"    ]. However, quitting smoking after age 60 years is still associated with a lower risk of death compared to older adults who continue to smoke [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/8,11,13\">",
"     8,11,13",
"    </a>",
"    ]. Even in smokers over age 80, quitting smoking appears to reduce mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936373\">",
"    <span class=\"h2\">",
"     Cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cigarette smoking is estimated to be responsible for &gt;10 percent of all cardiovascular deaths worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/14\">",
"     14",
"    </a>",
"    ] and 33 percent of all cardiovascular deaths in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nicotine from tobacco use can lead to several harmful effects on the cardiovascular system, including coronary vasoconstriction, increased hypercoagulability, dyslipidemia, and endothelial dysfunction. Smoking cessation is associated with a substantial reduction in the risk of cardiovascular events (including myocardial infarction, sudden cardiac death, and stroke) for both individuals with and without a prior history of cardiovascular disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=see_link\">",
"     \"Cardiovascular risk of smoking and benefits of smoking cessation\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    A meta-analysis of 20 prospective cohort studies found that quitting smoking after a heart attack or cardiac surgery decreases a patient's risk of death by more than one-third over a five year period [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/4\">",
"     4",
"    </a>",
"    ]. The beneficial impact of quitting smoking is as large or larger than the benefit of other secondary coronary heart disease interventions, such as cholesterol-lowering medications.",
"   </p>",
"   <p>",
"    Smoking cessation also reduces the progression of symptomatic peripheral artery disease and is associated with a reduced risk of recurrent stroke. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/21/32090?source=see_link&amp;anchor=H3#H3\">",
"     \"Medical management of claudication\", section on 'Cigarette smoking'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=see_link\">",
"     \"Secondary prevention of stroke: Risk factor reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936402\">",
"    <span class=\"h2\">",
"     Malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking is a major risk factor for many types of cancer (",
"    <a class=\"graphic graphic_table graphicRef57169 \" href=\"UTD.htm?0/41/668\">",
"     table 1",
"    </a>",
"    ), and tobacco cessation is associated with a reduction in cancer risk. Among smokers with a smoking-related cancer, smoking cessation may also decrease the risk of developing a second smoking-related malignancy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/16\">",
"     16",
"    </a>",
"    ]. The relationships between smoking and different types of cancer are discussed in detail separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12298?source=see_link\">",
"       \"Cigarette smoking and other risk factors for lung cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6759?source=see_link&amp;anchor=H11#H11\">",
"       \"Multiple primary lung cancers\", section on 'Smoking cessation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20583?source=see_link&amp;anchor=H4#H4\">",
"       \"Epidemiology and risk factors for head and neck cancer\", section on 'Smoking'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=see_link&amp;anchor=H13#H13\">",
"       \"Risk factors for gastric cancer\", section on 'Smoking'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27866?source=see_link&amp;anchor=H12#H12\">",
"       \"Epidemiology and risk factors for exocrine pancreatic cancer\", section on 'Cigarette smoking'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18250?source=see_link&amp;anchor=H6#H6\">",
"       \"Epidemiology, pathology, and pathogenesis of renal cell carcinoma\", section on 'Smoking'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26586?source=see_link&amp;anchor=H10#H10\">",
"       \"Epidemiology and etiology of urothelial (transitional cell) carcinoma of the bladder\", section on 'Smoking cessation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/23/25978?source=see_link&amp;anchor=H394569#H394569\">",
"       \"Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Epidemiology and risk factors\", section on 'Cigarette smoking'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31065?source=see_link&amp;anchor=H13#H13\">",
"       \"Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis\", section on 'Cigarette smoking'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=see_link&amp;anchor=H282027129#H282027129\">",
"       \"Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis\", section on 'Other factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link&amp;anchor=H13#H13\">",
"       \"Classification and epidemiology of anal cancer\", section on 'Cigarette smoking'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/24/42378?source=see_link&amp;anchor=H2#H2\">",
"       \"Cancer prevention\", section on 'Tobacco use'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14897691\">",
"    <span class=\"h2\">",
"     Pulmonary disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidemiologic studies indicate that cigarette smoking is overwhelmingly the most important risk factor for COPD.",
"   </p>",
"   <p>",
"    Smoking cessation reduces the accelerated decline of lung function and risk of incident COPD associated with smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/17\">",
"     17",
"    </a>",
"    ]. In addition, the majority of smokers with cough and sputum production with early COPD have an improvement in symptoms in the first 12 months after cessation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/18\">",
"     18",
"    </a>",
"    ]. The risk of COPD exacerbations also declines over time after smoking cessation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/60/6089?source=see_link&amp;anchor=H17#H17\">",
"     \"Chronic obstructive pulmonary disease: Risk factors and risk reduction\", section on 'Smoking cessation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Smoking is associated with other chronic lung conditions, including asthma and respiratory bronchiolitis. Smoking cessation leads to an improvement in respiratory symptoms in these patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=see_link&amp;anchor=H18#H18\">",
"     \"Risk factors for asthma\", section on 'Smoking and exposure to environmental tobacco smoke'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34633?source=see_link&amp;anchor=H92410128#H92410128\">",
"     \"Respiratory bronchiolitis-associated interstitial lung disease\", section on 'Smoking cessation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14897822\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cigarette smoking is associated with an increased risk of several types of infection, including tuberculosis, pneumococcal pneumonia, Legionnaires disease, meningococcal disease, influenza, and the common cold [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. Although smoking cessation may reduce the risk of several types of infection, there are little data available to support this. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=see_link&amp;anchor=H7#H7\">",
"     \"Epidemiology of tuberculosis\", section on 'Risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13386?source=see_link&amp;anchor=H5#H5\">",
"     \"Pneumococcal pneumonia in adults\", section on 'Smoking'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32680?source=see_link&amp;anchor=H8#H8\">",
"     \"Epidemiology and pathogenesis of Legionella infection\", section on 'Host risk factors'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27432?source=see_link&amp;anchor=H13#H13\">",
"     \"Epidemiology of Neisseria meningitidis infection\", section on 'Other host factors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H64327377\">",
"    <span class=\"h2\">",
"     Diabetes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of cigarettes smoked daily is associated with an increased risk for developing type 2 diabetes mellitus over the long-term. This may be partly due to nicotine&rsquo;s effect on impaired insulin sensitivity. Although there does appear to be an increased risk of developing type 2 diabetes shortly after quitting tobacco use (perhaps partly due to weight gain), smoking cessation reduces the risk of diabetes after several years of abstinence [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/24/9610?source=see_link&amp;anchor=H10#H10\">",
"     \"Risk factors for type 2 diabetes mellitus\", section on 'Smoking'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H64327479\">",
"    <span class=\"h2\">",
"     Osteoporosis and hip fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking accelerates bone loss and is a risk factor for hip fracture in women [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/23\">",
"     23",
"    </a>",
"    ]. Smoking cessation can reverse loss of bone mineral density and decrease the excess risk of hip fracture after approximately ten years after quitting tobacco use (RR 0.7, 95% CI 0.5-0.9) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/42/29354?source=see_link&amp;anchor=H23#H23\">",
"     \"Osteoporotic fracture risk assessment\", section on 'Cigarette smoking'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of the management of osteoporosis in postmenopausal women\", section on 'Cessation of smoking'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14897844\">",
"    <span class=\"h2\">",
"     Reproductive disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking is associated with an increased risk of several reproductive disorders, including complications during pregnancy, premature menopause, erectile dysfunction, and subfertility in both men and women. In particular, maternal smoking is associated with spontaneous abortion, ectopic pregnancy, lower birth weight, and a number of diseases in the fetus, some of which may develop late in life. Maternal smoking cessation results in improved fetal and maternal outcomes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27482?source=see_link\">",
"     \"Smoking and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936409\">",
"    <span class=\"h2\">",
"     Peptic ulcer disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastric and duodenal ulcer disease is more likely to occur and take more time to heal in smokers, compared to nonsmokers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/26\">",
"     26",
"    </a>",
"    ]. Smoking is associated with Helicobacter pylori infection, a well-established etiologic agent for peptic ulcer disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/27\">",
"     27",
"    </a>",
"    ]. Persistent smoking increases treatment failure rates for Helicobacter pylori eradication [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/27\">",
"     27",
"    </a>",
"    ]. Smoking cessation decreases the risk of developing peptic ulcer disease and accelerates the rate of healing in established disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/42/19113?source=see_link\">",
"     \"Epidemiology and etiology of peptic ulcer disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14894338\">",
"    <span class=\"h2\">",
"     Periodontal disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of cigarettes smoked daily is associated with an increased risk of developing periodontal disease, including gingivitis and periodontitis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/30\">",
"     30",
"    </a>",
"    ]. In a large population-based survey, the risk of periodontitis in former smokers declined with the number of years after smoking cessation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/31\">",
"     31",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18777?source=see_link\">",
"     \"Gingivitis and periodontitis in adults: Classification and dental treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936437\">",
"    <span class=\"h2\">",
"     Postoperative complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation prior to surgery may prevent postoperative complications, including delayed wound healing and pulmonary complications. In addition, longer periods of smoking cessation prior to surgery are associated with lower rates of postoperative complications. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10314?source=see_link&amp;anchor=H33505198#H33505198\">",
"     \"Preoperative medical evaluation of the healthy patient\", section on 'Smoking'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936451\">",
"    <span class=\"h1\">",
"     RISKS OF SMOKING CESSATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the risks of smoking cessation are far outweighed by the benefits, these risks are important to address in order to maximize the likelihood that a patient will successfully quit tobacco use. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936459\">",
"    <span class=\"h2\">",
"     Nicotine withdrawal syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine is a potent psychoactive drug that causes physical dependence and tolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/7\">",
"     7",
"    </a>",
"    ]. In the absence of nicotine, a smoker develops cravings for cigarettes and symptoms of the nicotine withdrawal syndrome. Symptoms generally peak in the first three days and subside over the next three to four weeks, but smokers&rsquo; cravings for cigarettes may persist for months to years. Nicotine withdrawal symptoms include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Increased appetite or weight gain",
"     </li>",
"     <li>",
"      Dysphoric or depressed mood",
"     </li>",
"     <li>",
"      Insomnia",
"     </li>",
"     <li>",
"      Irritability, frustration, or anger",
"     </li>",
"     <li>",
"      Anxiety",
"     </li>",
"     <li>",
"      Difficulty concentrating",
"     </li>",
"     <li>",
"      Restlessness",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These factors should be addressed, so that smokers will know what to expect and how to respond if these symptoms occur. Smoking cessation medications, including nicotine replacement therapy,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/2/15398?source=see_link\">",
"     varenicline",
"    </a>",
"    , relieve the symptoms of nicotine withdrawal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/13/17626?source=see_link\">",
"     \"Pharmacotherapy for smoking cessation in adults\"",
"    </a>",
"    .) Nonpharmacologic approaches can also help to manage nicotine withdrawal symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936473\">",
"    <span class=\"h2\">",
"     Weight gain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight gain commonly occurs after cessation of smoking. Weight gain is a principal fear of those who are considering smoking cessation, especially women. The mechanisms behind weight gain appear to be decreased metabolic rate, increased activity of lipoprotein lipase, changes in food preferences, and increased caloric intake [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/32\">",
"     32",
"    </a>",
"    ]. Weight gain of 1 to 2 kg in the first two weeks is usually followed by an additional 2 to 3 kg weight gain over the next four to five months [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. The average total weight gain is 4 to 5 kg, but may be much greater. Ten percent or more of quitters may gain over 13 kg after smoking cessation. In general, the amount of weight gain is greater in women than men, nonwhites compared to whites, and heavier smokers compared to lighter smokers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While there are well recognized health hazards of obesity (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    ), these are outweighed by the health benefits of quitting smoking, which are much larger than the additional risk conferred by the weight gain. Behavioral counseling that addresses weight gain, including dietary or physical activity interventions, has some success in limiting weight gain (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    ). Weight gain can also be temporarily blunted in smokers who quit with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/29/26073?source=see_link\">",
"     bupropion",
"    </a>",
"    , an antidepressant medication effective for smoking cessation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/13/17626?source=see_link&amp;anchor=H13311180#H13311180\">",
"     \"Pharmacotherapy for smoking cessation in adults\", section on 'Bupropion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936480\">",
"    <span class=\"h2\">",
"     Depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine withdrawal syndrome includes symptoms of depression and anxiety, particularly in those with a history of psychiatric illness. In patients with documented depression, smoking cessation has been reported to trigger depressive episodes that require behavioral counseling, antidepressant medication, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/36,37\">",
"     36,37",
"    </a>",
"    ]. However, despite this increase in depressive symptoms, subsequent studies have found that the benefits of smoking cessation outweigh the risks in patients with psychiatric illness [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=see_link\">",
"     \"Clinical manifestations and diagnosis of depression\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is unclear if smoking cessation causes depression in smokers who do not have psychiatric illness at baseline. In one large cohort of smokers without depression or anxiety, there was no increase in symptoms of depression or anxiety after quitting tobacco use [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H64327938\">",
"    <span class=\"h2\">",
"     Cough and mouth ulcers",
"    </span>",
"    &nbsp;&mdash;&nbsp;A temporary increase in cough and aphthous ulcers can occur in the first few weeks after stopping smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. The pathophysiology is not well-understood. Coughing and aphthous ulcers generally resolve several weeks after the quit date. Individuals with bronchitis who quit may also report an increase in cough, but the most common experience is a decrease is symptoms as noted above [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936501\">",
"    <span class=\"h1\">",
"     COST-EFFECTIVENESS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation interventions, including both counseling and medications, are highly cost-effective when compared to other commonly accepted preventive health practices (",
"    <a class=\"graphic graphic_table graphicRef78943 \" href=\"UTD.htm?0/45/732\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/44,45\">",
"     44,45",
"    </a>",
"    ]. One study examined several smoking cessation strategies with and without nicotine replacement and calculated an approximate cost of $2587 per net year of life gained, based upon published estimates of success and mortality differences for smokers and nonsmokers [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/45\">",
"     45",
"    </a>",
"    ]. A second study examined smokers at a single institution who completed an initial 60-minute nicotine dependence consultation and six two-hour evening sessions devoted to smoking cessation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/44\">",
"     44",
"    </a>",
"    ]. The cohort was followed for one year, and based upon quit rates at that time and published mortality rates by age, sex, smoking status, and number of years since quitting, a mathematical model estimated a cost of $6828 per net year of life gained. Both of these estimates are considerably more favorable than those of other common interventions. As one example, treatment of mild hypertension costs approximately $24,000 per net year of life gained [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Subsequent studies have found several behavioral and pharmacologic therapies for smoking cessation to be cost-effective [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/47\">",
"     47",
"    </a>",
"    ]. Telephone quitlines appear to be among the most cost effectiveness strategies [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18968/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=see_link\">",
"       \"Patient information: Quitting smoking (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"       \"Patient information: Quitting smoking (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30936515\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cigarette smoking is the leading preventable cause of mortality and is estimated to cause nearly six million deaths worldwide each year. Up to one half of all regular smokers can be expected to die from a tobacco-related illness. The most important causes of smoking-related mortality are atherosclerotic cardiovascular disease, lung cancer, and chronic obstructive pulmonary disease (COPD).(See",
"      <a class=\"local\" href=\"#H87359850\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Smoking cessation is associated with substantial health benefits, including a reduced risk of coronary heart disease, cancer, pulmonary disease, infections, and hip fracture. Smokers also benefit from quitting smoking even after the development of smoking-related diseases, such as coronary heart disease or COPD. (See",
"      <a class=\"local\" href=\"#H2589684\">",
"       'Benefits of smoking cessation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Smoking cessation is associated with a mortality benefit for both men and women of all ages. Stopping smoking before age 40 is associated with a larger decline in premature mortality than stopping at a later age. (See",
"      <a class=\"local\" href=\"#H64327338\">",
"       'All-cause mortality'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Smoking cessation often leads to nicotine withdrawal symptoms, including increased appetite, weight gain, depressive symptoms, anxiety, insomnia, irritability, difficulty concentrating, and restlessness. Nicotine withdrawal symptoms are temporary and can be treated by pharmacological or behavioral treatments. (See",
"      <a class=\"local\" href=\"#H30936451\">",
"       'Risks of smoking cessation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since tobacco use is both a learned behavior and a physical addiction to nicotine for the majority of smokers, the most effective way to promote smoking cessation is to combine both behavioral and pharmacological therapies, which have a higher quit rate than either therapy alone. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=see_link\">",
"       \"Overview of smoking cessation management in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     World Health Organization Report on the Global Tobacco Epidemic, 2011: Warning about the dangers of tobacco. World Health Organization, Geneva 2011. file://whqlibdoc.who.int/publications/2011/9789240687813_eng.pdf (Accessed on September 27, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/2\">",
"      Centers for Disease Control and Prevention (CDC). Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep 2008; 57:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/3\">",
"      Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/4\">",
"      Critchley J, Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 2004; :CD003041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/5\">",
"      Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005; 142:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/6\">",
"      Maciosek MV, Coffield AB, Edwards NM, et al. Priorities among effective clinical preventive services: results of a systematic review and analysis. Am J Prev Med 2006; 31:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/7\">",
"      Rigotti NA. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 2002; 346:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/8\">",
"      Vollset SE, Tverdal A, Gjessing HK. Smoking and deaths between 40 and 70 years of age in women and men. Ann Intern Med 2006; 144:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/9\">",
"      Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. Smoking and smoking cessation in relation to mortality in women. JAMA 2008; 299:2037.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/10\">",
"      Ikeda F, Ninomiya T, Doi Y, et al. Smoking cessation improves mortality in Japanese men: the Hisayama study. Tob Control 2012; 21:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/11\">",
"      Cao Y, Kenfield S, Song Y, et al. Cigarette smoking cessation and total and cause-specific mortality: a 22-year follow-up study among US male physicians. Arch Intern Med 2011; 171:1956.",
"     </a>",
"    </li>",
"    <li>",
"     Health benefits of smoking cessation. A report of the Surgeon General. DHHS Publication No. (CDC) 90-8416, Department of Health and Human Services, Washington, DC 1990.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/13\">",
"      Gellert C, Sch&ouml;ttker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med 2012; 172:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/14\">",
"      Ezzati M, Henley SJ, Thun MJ, Lopez AD. Role of smoking in global and regional cardiovascular mortality. Circulation 2005; 112:489.",
"     </a>",
"    </li>",
"    <li>",
"     Office of the Surgeon General. Chapter Six: Cardiovascular diseases. In: A Report of the Surgeon General: How Tobacco Smoke Causes Disease. US Department of Health and Human Services 2011. Available at: file://www.surgeongeneral.gov/library/tobaccosmoke/report/chapter6.pdf (Accessed on December 06, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/16\">",
"      Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 2004; 96:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/17\">",
"      Willemse BW, Postma DS, Timens W, ten Hacken NH. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23:464.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/18\">",
"      Kanner RE, Connett JE, Williams DE, Buist AS. Effects of randomized assignment to a smoking cessation intervention and changes in smoking habits on respiratory symptoms in smokers with early chronic obstructive pulmonary disease: the Lung Health Study. Am J Med 1999; 106:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/19\">",
"      Au DH, Bryson CL, Chien JW, et al. The effects of smoking cessation on the risk of chronic obstructive pulmonary disease exacerbations. J Gen Intern Med 2009; 24:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/20\">",
"      Arcavi L, Benowitz NL. Cigarette smoking and infection. Arch Intern Med 2004; 164:2206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/21\">",
"      Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/22\">",
"      Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007; 298:2654.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/23\">",
"      Kanis JA, Johnell O, Oden A, et al. Smoking and fracture risk: a meta-analysis. Osteoporos Int 2005; 16:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/24\">",
"      Cornuz J, Feskanich D, Willett WC, Colditz GA. Smoking, smoking cessation, and risk of hip fracture in women. Am J Med 1999; 106:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/25\">",
"      Oncken C, Prestwood K, Kleppinger A, et al. Impact of smoking cessation on bone mineral density in postmenopausal women. J Womens Health (Larchmt) 2006; 15:1141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/26\">",
"      Parasher G, Eastwood GL. Smoking and peptic ulcer in the Helicobacter pylori era. Eur J Gastroenterol Hepatol 2000; 12:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/27\">",
"      Suzuki T, Matsuo K, Ito H, et al. Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med 2006; 119:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/28\">",
"      Fagerstr&ouml;m K. The epidemiology of smoking: health consequences and benefits of cessation. Drugs 2002; 62 Suppl 2:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/29\">",
"      Tatsuta M, Iishi H, Okuda S. Effects of cigarette smoking on the location, healing and recurrence of gastric ulcers. Hepatogastroenterology 1987; 34:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/30\">",
"      Zee KY. Smoking and periodontal disease. Aust Dent J 2009; 54 Suppl 1:S44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/31\">",
"      Tomar SL, Asma S. Smoking-attributable periodontitis in the United States: findings from NHANES III. National Health and Nutrition Examination Survey. J Periodontol 2000; 71:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/32\">",
"      Filozof C, Fern&aacute;ndez Pinilla MC, Fern&aacute;ndez-Cruz A. Smoking cessation and weight gain. Obes Rev 2004; 5:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/33\">",
"      Chinn S, Jarvis D, Melotti R, et al. Smoking cessation, lung function, and weight gain: a follow-up study. Lancet 2005; 365:1629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/34\">",
"      Flegal KM, Troiano RP, Pamuk ER, et al. The influence of smoking cessation on the prevalence of overweight in the United States. N Engl J Med 1995; 333:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/35\">",
"      Williamson DF, Madans J, Anda RF, et al. Smoking cessation and severity of weight gain in a national cohort. N Engl J Med 1991; 324:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/36\">",
"      Covey LS. Tobacco cessation among patients with depression. Prim Care 1999; 26:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/37\">",
"      Glassman AH, Covey LS, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet 2001; 357:1929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/38\">",
"      Schroeder SA. Depression, smoking, and heart disease: how can psychiatrists be effective? Am J Psychiatry 2011; 168:876.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/39\">",
"      Prochaska JJ. Smoking and mental illness--breaking the link. N Engl J Med 2011; 365:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/40\">",
"      Bolam B, West R, Gunnell D. Does smoking cessation cause depression and anxiety? Findings from the ATTEMPT cohort. Nicotine Tob Res 2011; 13:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/41\">",
"      Ussher M, West R, Steptoe A, McEwen A. Increase in common cold symptoms and mouth ulcers following smoking cessation. Tob Control 2003; 12:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/42\">",
"      Marakolu K, Sezer RE, Toker HC, Marakolu I. The recurrent aphthous stomatitis frequency in the smoking cessation people. Clin Oral Investig 2007; 11:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/43\">",
"      Dicpinigaitis PV, Sitkauskiene B, Stravinskaite K, et al. Effect of smoking cessation on cough reflex sensitivity. Eur Respir J 2006; 28:786.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/44\">",
"      Croghan IT, Offord KP, Evans RW, et al. Cost-effectiveness of treating nicotine dependence: the Mayo Clinic experience. Mayo Clin Proc 1997; 72:917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/45\">",
"      Cromwell J, Bartosch WJ, Fiore MC, et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA 1997; 278:1759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/46\">",
"      Karnath B. Smoking cessation. Am J Med 2002; 112:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/47\">",
"      Javitz HS, Zbikowski SM, Deprey M, et al. Cost-effectiveness of varenicline and three different behavioral treatment formats for smoking cessation. Transl Behav Med 2011; 1:182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18968/abstract/48\">",
"      Shearer J, Shanahan M. Cost effectiveness analysis of smoking cessation interventions. Aust N Z J Public Health 2006; 30:428.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16706 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-115.25.216.6-E17AAC726A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18968=[""].join("\n");
var outline_f18_33_18968=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30936515\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H87359850\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2589684\">",
"      BENEFITS OF SMOKING CESSATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H64327338\">",
"      All-cause mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30936373\">",
"      Cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30936402\">",
"      Malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14897691\">",
"      Pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14897822\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H64327377\">",
"      Diabetes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H64327479\">",
"      Osteoporosis and hip fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14897844\">",
"      Reproductive disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30936409\">",
"      Peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14894338\">",
"      Periodontal disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30936437\">",
"      Postoperative complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30936451\">",
"      RISKS OF SMOKING CESSATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30936459\">",
"      Nicotine withdrawal syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30936473\">",
"      Weight gain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30936480\">",
"      Depression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H64327938\">",
"      Cough and mouth ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30936501\">",
"      COST-EFFECTIVENESS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30936515\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/16706\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/16706|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/41/668\" title=\"table 1\">",
"      Tobacco associated cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/45/732\" title=\"table 2\">",
"      Comparative cost effectiveness",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/24/42378?source=related_link\">",
"      Cancer prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/13/26840?source=related_link\">",
"      Carcinoma of the penis: Epidemiology, risk factors, staging, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1482?source=related_link\">",
"      Cardiovascular risk of smoking and benefits of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31065?source=related_link\">",
"      Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/60/6089?source=related_link\">",
"      Chronic obstructive pulmonary disease: Risk factors and risk reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/0/12298?source=related_link\">",
"      Cigarette smoking and other risk factors for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=related_link\">",
"      Classification and epidemiology of anal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/13/11481?source=related_link\">",
"      Clinical manifestations and diagnosis of depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/42/19113?source=related_link\">",
"      Epidemiology and etiology of peptic ulcer disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26586?source=related_link\">",
"      Epidemiology and etiology of urothelial (transitional cell) carcinoma of the bladder",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/58/32680?source=related_link\">",
"      Epidemiology and pathogenesis of Legionella infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/13/27866?source=related_link\">",
"      Epidemiology and risk factors for exocrine pancreatic cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20583?source=related_link\">",
"      Epidemiology and risk factors for head and neck cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/50/27432?source=related_link\">",
"      Epidemiology of Neisseria meningitidis infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/13/18649?source=related_link\">",
"      Epidemiology of tuberculosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/52/18250?source=related_link\">",
"      Epidemiology, pathology, and pathogenesis of renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/23/25978?source=related_link\">",
"      Epithelial carcinoma of the ovary, fallopian tube, and peritoneum: Epidemiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/21/18777?source=related_link\">",
"      Gingivitis and periodontitis in adults: Classification and dental treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/21/32090?source=related_link\">",
"      Medical management of claudication",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/38/6759?source=related_link\">",
"      Multiple primary lung cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/42/29354?source=related_link\">",
"      Osteoporotic fracture risk assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/3/23609?source=related_link\">",
"      Overview of smoking cessation management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39754?source=related_link\">",
"      Overview of the management of osteoporosis in postmenopausal women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=related_link\">",
"      Patient information: Quitting smoking (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/13/17626?source=related_link\">",
"      Pharmacotherapy for smoking cessation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/4/13386?source=related_link\">",
"      Pneumococcal pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10314?source=related_link\">",
"      Preoperative medical evaluation of the healthy patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/52/34633?source=related_link\">",
"      Respiratory bronchiolitis-associated interstitial lung disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/12/20682?source=related_link\">",
"      Risk factors for asthma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/38/618?source=related_link\">",
"      Risk factors for gastric cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/24/9610?source=related_link\">",
"      Risk factors for type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=related_link\">",
"      Secondary prevention of stroke: Risk factor reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/53/27482?source=related_link\">",
"      Smoking and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/38/12904?source=related_link\">",
"      Smoking cessation counseling strategies in primary care",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_33_18969="Clinical manifestations of giant cell (temporal) arteritis";
var content_f18_33_18969=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations of giant cell (temporal) arteritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18969/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18969/contributors\">",
"     Gene G Hunder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18969/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18969/contributors\">",
"     John H Stone, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18969/contributors\">",
"     Jonathan Trobe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?18/33/18969/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?18/33/18969/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?18/33/18969/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 16, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Giant cell arteritis (GCA) is a chronic vasculitis of large- and medium-sized vessels. The mean age at diagnosis is approximately 72 years, and the disease essentially never occurs in individuals younger than 50 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/1\">",
"     1",
"    </a>",
"    ]. Among individuals older than 50, the prevalence of GCA has been estimated to be 1 in 500 individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although systemic symptoms are characteristic of GCA and although vascular involvement may be widespread, blood vessel inflammation most frequently involves the cranial branches of the arteries that originate from the aortic arch [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The most feared complication of GCA, visual loss, is one potential result of the cranial arteritis associated with this disease.",
"   </p>",
"   <p>",
"    The clinical manifestations of GCA will be reviewed here. The pathogenesis, diagnosis, and treatment of this disorder are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/62/8166?source=see_link\">",
"     \"Pathogenesis of giant cell (temporal) arteritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34599?source=see_link\">",
"     \"Diagnosis of giant cell (temporal) arteritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/26/34217?source=see_link\">",
"     \"Treatment of giant cell (temporal) arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION CRITERIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Criteria for the classification of GCA have been formulated by the American College of Rheumatology (ACR) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/5\">",
"     5",
"    </a>",
"    ]. These criteria were designed for the purpose of differentiating GCA from other forms of vasculitis in research studies; they are not meant to be diagnostic criteria.",
"   </p>",
"   <p>",
"    In the ACR classification study, the symptoms and findings of 214 patients with the diagnosis of GCA were compared with the clinical findings of 593 patients with other forms of vasculitis. The following classification criteria were effective in distinguishing GCA from other forms of vasculitis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age greater than or equal to 50 years at time of disease onset",
"     </li>",
"     <li>",
"      Localized headache of new onset",
"     </li>",
"     <li>",
"      Tenderness or decreased pulse of the temporal artery",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate (ESR) greater than 50",
"      <span class=\"nowrap\">",
"       mm/hour",
"      </span>",
"     </li>",
"     <li>",
"      Biopsy revealing a necrotizing arteritis with a predominance of mononuclear cells or a granulomatous process with multinucleated giant cells",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Given that a patient has a diagnosis of some form of vasculitis, the presence of three of these five criteria is associated with a 94 percent sensitivity and a 91 percent specificity for the diagnosis of GCA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The greatest risk factor for developing GCA is aging. The disease almost never occurs before age 50, and its incidence rises steadily thereafter. In a pooled analysis of 1435 patients from 26 studies of patients with biopsy-proven GCA, only two patients were younger than 50 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/1\">",
"     1",
"    </a>",
"    ]. Furthermore, the diagnosis in those two cases may be called into question, given the propensity of other forms of vasculitis to involve the temporal arteries with pathologic findings sometimes indistinguishable from early GCA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to age, ethnicity is a risk factor for GCA. The highest incidence figures are found in Scandinavian countries and among Americans of Scandinavian descent. The annual incidence of GCA in Olmsted County, Minnesota is similar to that in Scandinavian countries: approximately 1 in 4200 individuals over the age of 50 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The similar incidence calculations across these countries probably reflect shared genetic risk factors for this condition, as many of the inhabitants of Olmsted County during the period of study were descended from Scandinavians and northern Europeans. Reports of familial aggregation in GCA are common. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/62/8166?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis of giant cell (temporal) arteritis\", section on 'Etiology and pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Based upon 2000 census data, the prevalence of GCA in the entire United States is approximately 160,000. Autopsy studies suggest that subclinical GCA may be common. One study from Sweden found arteritis in 1.6 percent of 889 postmortem cases in which sections of the temporal artery and two transverse sections of the aorta were made [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both the history and the physical examination are essential to establishing the diagnosis of GCA. Although many of the clinical manifestations of GCA are nonspecific, some characteristic findings strongly suggest the diagnosis (",
"    <a class=\"graphic graphic_table graphicRef54634 \" href=\"UTD.htm?9/7/9341\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The onset of symptoms in GCA tends to be gradual, but abrupt presentations occur in some patients. When taking the patient&rsquo;s history, the clinician must ask about the following types of symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Systemic complaints",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic symptoms include fever, fatigue, and weight loss. Fevers occur in up to one-half of patients with GCA and are usually low-grade. However, in approximately 15 percent of patients, the fevers exceed 39&ordm;C (102.2&ordm;F), often leading to misdiagnoses of infections [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/9\">",
"     9",
"    </a>",
"    ]. In approximately 10 percent of patients, constitutional symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    laboratory evidence of inflammation are the only clues to the presence of GCA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H35\">",
"     'Laboratory findings'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Headache",
"    </span>",
"    &nbsp;&mdash;&nbsp;A new headache occurs in at least two-thirds of patients. A headache may have a variety of presentations in GCA, but its critical feature is that it is new. Although headache is the chief complaint in many patients presenting with GCA, in some, this symptom must be elicited by direct questioning.",
"   </p>",
"   <p>",
"    The classic GCA headache is located in temporal regions. However, GCA headaches may also occur in frontal or occipital areas or may be generalized. The headaches may become progressively worse, but they can also wax and wane, sometimes subsiding temporarily before treatment is started.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Jaw claudication",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly one-half of GCA patients suffer from jaw claudication. In some cases, a trismus-like symptom occurs rather than fatigue of the chewing muscles. Two other striking features of jaw claudication are how quickly the symptom occurs after the start of chewing and how much the pain disables the patient. Patients seldom recognize the significance of jaw claudication symptoms and must be queried directly about them.",
"   </p>",
"   <p>",
"    Jaw claudication was the most specific symptom of GCA in a study of the diagnostic value of temporal artery biopsies, which correlated positive biopsies with clinical symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/13\">",
"     13",
"    </a>",
"    ]. Among 134 patients who underwent temporal artery biopsy, jaw claudication was present in 54 percent of those with positive biopsies, compared with only 3 percent of those whose biopsies were negative. Claudication-like symptoms occasionally occur with repeated swallowing and in the tongue with eating.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Visual symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of visual manifestations occur in GCA. In many cases, ocular involvement is heralded by the development of amaurosis fugax (transient monocular loss of vision). Episodes of amaurosis fugax in GCA may be caused by transient ischemia of the retina, choroid, or optic nerve or by a combination of these structures and may be followed by anterior ischemic optic neuropathy (AION), by central or branch retinal arterial occlusion, or by choroidal infarction [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Visual loss remains common in GCA, even in the era of effective therapy. Permanent partial or complete loss of vision in one or both eyes occurs in 15 to 20 percent of patients with GCA in most series [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/15\">",
"     15",
"    </a>",
"    ]. The high frequency of visual loss despite the availability of effective treatment relates to the fact that visual loss is the presenting feature in many patients (ie, the disease manifestation that finally causes them to seek medical attention).",
"   </p>",
"   <p>",
"    Specific visual syndromes that may be associated with GCA are discussed below. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Specific visual syndromes'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Polymyalgia rheumatica",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymyalgia rheumatica (PMR) is characterized by aching and morning stiffness in the shoulder and hip girdles, in the neck, and in the torso. PMR is closely linked to GCA, occurring in about 40 to 50 percent of patients. Conversely, GCA is found in about 15 percent of patients with PMR. Approximately 5 percent of patients with symptoms suggesting isolated PMR (without symptoms of arteritis) who undergo temporal artery biopsy are found to have GCA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/11,16,17\">",
"     11,16,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13832?source=see_link\">",
"     \"Clinical manifestations and diagnosis of polymyalgia rheumatica\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The precise nature of the relationship between GCA and PMR is not completely understood. Some patients have symptoms and findings limited to GCA or to PMR throughout the course of their illness, while others have manifestations of both, either simultaneously or at different times. The population of patients affected most commonly by these disorders and the genetic susceptibility for the two conditions appear to be similar. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/62/8166?source=see_link\">",
"     \"Pathogenesis of giant cell (temporal) arteritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Other musculoskeletal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Musculoskeletal symptoms in addition to those of PMR have been observed in patients with GCA. These include symptoms resulting from peripheral synovitis and distal extremity swelling with pitting edema, both of which occur in a minority of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/18\">",
"     18",
"    </a>",
"    ]. Distal extremity swelling in GCA (and PMR) may occur in the context of a clinical syndrome known as remitting seronegative symmetrical synovitis with pitting edema, abbreviated RS3PE [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/19\">",
"     19",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13832?source=see_link&amp;anchor=H14#H14\">",
"     \"Clinical manifestations and diagnosis of polymyalgia rheumatica\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Upper respiratory tract",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 percent of patients with GCA have upper respiratory tract symptoms. These include a cough that is nonproductive and that leads to significant diagnostic confusion [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/20\">",
"     20",
"    </a>",
"    ]. Cough associated with GCA is thought to result from vasculitis in the area of cough receptors, which are located throughout the respiratory tree.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Arm claudication",
"    </span>",
"    &nbsp;&mdash;&nbsp;In approximately 3 to 15 percent of cases, the branches of the aortic arch, particularly the subclavian and axillary arteries, become sufficiently narrowed to produce arm claudication [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/4,11,21,22\">",
"     4,11,21,22",
"    </a>",
"    ]. Gradual tapering of these vessels is typical of the large-vessel involvement seen with GCA (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73553 \" href=\"UTD.htm?6/12/6343\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/4,23\">",
"     4,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study characterized the clinical features of 74 patients with angiographically diagnosed",
"    <span class=\"nowrap\">",
"     subclavian/axillary",
"    </span>",
"    GCA (large-vessel GCA) and of 74 patients with biopsy-proven temporal artery GCA (cranial artery GCA) [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/21\">",
"     21",
"    </a>",
"    ]. Compared with those with cranial artery GCA, patients with large-vessel GCA were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Younger at disease onset (66 versus 72 years)",
"     </li>",
"     <li>",
"      Less likely to have headaches (14 versus 57 percent)",
"     </li>",
"     <li>",
"      More likely to have arm claudication at presentation (51 versus 0 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Among the 57 patients with large-vessel GCA in whom a temporal artery biopsy was eventually performed, positive findings were found in only 33 (58 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Aneurysms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic involvement appears to be a relatively common feature of GCA. This was illustrated in a study of 22 patients and 22 controls in which helical computerized tomography (CT) scanning was performed within four weeks of a positive temporal artery biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/24\">",
"     24",
"    </a>",
"    ]. Aortic wall thickening was significantly more frequent in the patients with GCA (45 versus 14 percent).",
"   </p>",
"   <p>",
"    The development of aortic aneurysms (ascending more common than descending) is a late and potentially serious complication of GCA that warrants ongoing monitoring (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef72571 \" href=\"UTD.htm?30/52/31566\">",
"     image 2",
"    </a>",
"    ). Aortic aneurysms can be caused by one of two mechanisms: chronic or late recrudescent aortitis causing elastin and collagen disruption, or mechanical stress on an aortic wall that was weakened in the early active phase of the disease.",
"   </p>",
"   <p>",
"    Several studies have documented the incidence and serious consequences of aneurysm formation [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/3,4,17,22,25-27\">",
"     3,4,17,22,25-27",
"    </a>",
"    ]. The following observations illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a series of 96 patients with GCA from Olmsted County, 11 (11 percent) developed thoracic aortic aneurysms. In nine of these patients, the median time to the diagnosis of aneurysm following the diagnosis of GCA was 5.8 years [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/26\">",
"       26",
"      </a>",
"      ]. Patients with GCA were 17 times more likely to develop thoracic aortic aneurysms and 2.4 times more likely to develop isolated abdominal aortic aneurysms than were other persons of the same age and sex in Olmsted County.",
"     </li>",
"     <li>",
"      In an overlapping study of 41 patients with GCA who developed thoracic aortic aneurysms, three developed aneurysms before GCA was diagnosed, and, in five patients, GCA and aneurysms were diagnosed simultaneously [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/3\">",
"       3",
"      </a>",
"      ]. In the remaining 33 patients, the aneurysms were diagnosed a median of seven years after GCA. Active aortitis was found in about one-half of specimens examined at surgery or autopsy.",
"     </li>",
"     <li>",
"      In a later report of 287 patients, of whom 18 (11 percent) developed thoracic aortic aneurysms, nine patients developed aortic dissection [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Aortic dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic dissection can occur in the presence or absence of aneurysmal dilation of the aorta. In a cohort of 168 patients with biopsy-proven GCA, 10 had aortic dissections, nine of which affected the thoracic aorta and one of which affected the abdominal aorta [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Central nervous system involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Documented involvement of intracranial vessels in GCA is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. The largest reported experience comes from a review of 463 patients with a clinical diagnosis of central nervous system vasculitis at the Mayo Clinic; only two patients had compelling evidence of intracranial GCA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When transient ischemic attacks, vertigo, hearing loss, and stroke occur in GCA, they are most often due to vertebral artery involvement or to internal carotid lesions that are extradural in location [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/28,30-32\">",
"     28,30-32",
"    </a>",
"    ]. Carotid and vertebrobasilar involvement may result from vasculitis affecting these vessels or from aortic dissection [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/22\">",
"     22",
"    </a>",
"    ]. Among a group of 18 patients whose deaths were directly attributed to GCA, three were due to stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vertebral artery disease causing posterior circulation problems in GCA is more common than carotid involvement. Rapidly progressive brainstem",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cerebellar neurologic deficits may be due to bilateral vertebral artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Other manifestations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of unusual presentations of GCA have been reported. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tongue pain and tongue infarction [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Throat pain [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Tumor-like masses in the breast [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/37\">",
"       37",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      The syndrome of inappropriate antidiuretic hormone secretion [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/35,36\">",
"       35,36",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Mononeuritis multiplex [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/32\">",
"       32",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Sensorineural hearing loss [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/38\">",
"       38",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Dysarthria [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/39\">",
"       39",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Mesenteric ischemia [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with GCA often appear chronically ill. In addition, specific findings related to involvement of characteristic arteries may be present.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Pulses",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulses may be diminished in the setting of large-vessel disease. Thus, on each visit, the clinician should palpate the carotid, brachial, radial, femoral, and pedal pulses. Pulse discrepancies may be associated with blood pressure differences in the arms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Temporal artery abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tender or thickened temporal or other cranial arteries can occur (",
"    <a class=\"graphic graphic_picture graphicRef77618 \" href=\"UTD.htm?42/61/43998\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A meta-analysis performed to identify the utility of various clinical features in the diagnosis of GCA included 21 studies reported between 1996 and 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/1\">",
"     1",
"    </a>",
"    ]. The studies represented a total of 2680 patients who had undergone temporal artery biopsy, of whom 1050 (39 percent) had biopsy-proven GCA. Likelihood ratios (LR) for positive temporal artery biopsies were calculated for various features of the physical examination.",
"   </p>",
"   <p>",
"    The following observations were made:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prominent or enlarged temporal artery &mdash; LR 4.3 (ie, a patient with such a finding was more than four times as likely to have a positive temporal artery biopsy than one without such a finding)",
"     </li>",
"     <li>",
"      An absent temporal artery pulse &mdash; LR 2.7",
"     </li>",
"     <li>",
"      Temporal artery tenderness &mdash; LR 2.6",
"     </li>",
"     <li>",
"      Synovitis &mdash; associated with an LR below 1 because synovitis is more typical of other disorders such as rheumatoid arthritis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These findings illustrate the importance of the physical examination in evaluating patients with possible GCA. However, one-third of patients with biopsy-proven GCA have normal temporal arteries on clinical examination [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Eye examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a patient with amaurosis fugax, the ophthalmologic examination may be entirely normal. Some patients have cotton wool spots in the retina, depending upon the site of critical vascular lesions.",
"   </p>",
"   <p>",
"    In patients with acute visual loss from AION, fundoscopic examination shows changes of ischemic optic neuropathy with a swollen pale disc and blurred margins (",
"    <a class=\"graphic graphic_picture graphicRef70141 \" href=\"UTD.htm?20/46/21230\">",
"     picture 2",
"    </a>",
"    ). In patients with permanent visual loss (ie, the great majority of those with AION), later findings include optic atrophy and a pale, flat disc. Such patients will demonstrate a relative afferent pupillary defect, manifested by a Marcus-Gunn pupil or by a positive &ldquo;swinging flashlight sign.&rdquo;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Musculoskeletal findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with PMR, active range of motion of the shoulders, neck, and hips is limited due to pain. The shoulders may be tender to palpation, but these findings are usually less prominent than the severity of the symptoms. Approximately 15 to 20 percent of patients have mild to moderate synovitis, especially in the wrists and knees [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/42\">",
"     42",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13832?source=see_link\">",
"     \"Clinical manifestations and diagnosis of polymyalgia rheumatica\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Bruits",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bruits may be heard on auscultation of the carotid or supraclavicular areas; over the axillary, brachial, or femoral arteries; over the abdominal aorta; and, rarely, over the orbits. Auscultation of these areas should be performed regularly by the examiner.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Cardiac auscultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Murmurs of aortic regurgitation are important to exclude, because they may signal the development of an ascending aortic aneurysm with secondary dilatation of the aortic valve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Specific visual syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of ocular syndromes are associated with GCA. The most common are amaurosis fugax and anterior ischemic optic neuropathy. It is estimated that bilateral blindness will develop in 25 to 50 percent of untreated patients who present with loss of vision in one eye [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Amaurosis fugax",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient vision impairment is often an early manifestation of GCA. Affected patients typically note an abrupt partial field defect in one eye. Although this lesion may resolve, it can also progress to total monocular blindness or can return at a later time to cause permanent visual loss. If the patient with monocular visual loss is left untreated, the second eye is likely to become affected within one to two weeks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/26/10666?source=see_link&amp;anchor=H16#H16\">",
"     \"Amaurosis fugax (transient monocular or binocular visual loss)\", section on 'Other ischemic etiologies'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Anterior ischemic optic neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anterior ischemic optic neuropathy (AION) is the most common ocular presentation of GCA. However, only about 5 percent of individuals with AION have GCA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    AION in GCA is usually unilateral at presentation, but contralateral disease can occur within days or weeks if treatment is not begun immediately or is stopped while the disease is still active.",
"   </p>",
"   <p>",
"    The ischemic insult in AION is typically due to occlusive disease or to thrombosis of the posterior ciliary arteries, which supply the optic nerve. However, the ophthalmic artery may also be affected, either by vasculitis or by microemboli [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Central retinal artery occlusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Central retinal artery occlusion (CRAO) is responsible for approximately 10 percent of the cases of visual loss in GCA. On the other hand, approximately 2 percent of older patients with CRAO have underlying GCA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/46-48\">",
"     46-48",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3882?source=see_link&amp;anchor=H10#H10\">",
"     \"Central and branch retinal artery occlusion\", section on 'Inflammatory disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Diplopia",
"    </span>",
"    &nbsp;&mdash;&nbsp;In GCA, diplopia may result from ischemic damage to almost any portion of the oculomotor system, from ischemia to the extraocular muscles, from paresis of an ocular motor nerve, and from brainstem disease. Diplopia occurs in approximately 10 percent of patients with GCA and has a high specificity in patients with other suggestive symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/13,25\">",
"     13,25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Posterior ischemic optic neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Posterior ischemic optic neuropathy (PION) results from the interruption of blood flow to the retrobulbar portion of the optic nerve. Less than 5 percent of patients with GCA develop PION. Histopathologic examination typically reveals inflammatory occlusion of the ophthalmic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    short posterior ciliary arteries [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A variety of other ocular syndromes are less common manifestations in patients with GCA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Branch retinal artery occlusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Branch retinal artery occlusion (BRAO) occurs less frequently in patients with GCA than does CRAO. Nevertheless, patients with GCA may develop isolated BRAO in one or both eyes from reduction of blood flow through either the ophthalmic or the central retinal arteries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Bitemporal hemianopia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bitemporal visual field defects may occur in patients with GCA from vasculitic damage to the arteries supplying the optic chiasm.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Homonymous hemianopia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Homonymous hemianopia is a visual field defect involving either the two right or the two left halves of the visual fields of both eyes. In patients with GCA, it results from vascular damage to the retrochiasmal visual sensory pathways. The most common cause in GCA is an occipital lobe infarction resulting from a lesion in the vertebrobasilar circulation. In rare cases, bilateral occipital lobe involvement leads to bilateral homonymous field defects and to the development of cortical blindness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/61/37848?source=see_link\">",
"     \"Homonymous hemianopia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h3\">",
"     Visual hallucinations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Visual hallucinations in GCA may be due to the Charles Bonnet syndrome (also called release hallucinations) or to a glucocorticoid-induced psychosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=see_link&amp;anchor=H21#H21\">",
"     \"Major side effects of systemic glucocorticoids\", section on 'Central nervous system'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The Charles Bonnet syndrome refers to the occurrence of visual hallucinations in psychologically normal individuals who have visual loss due to lesions in either peripheral or central visual pathways. The visual hallucinations may be glucocorticoid-responsive [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/50\">",
"     50",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32886?source=see_link\">",
"     \"Visual release hallucinations (Charles Bonnet syndrome)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Laboratory findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory findings that are useful in the assessment of GCA include routine hematological testing, selected serum chemistry tests, ESR, and C-reactive protein (CRP). Measurement of interleukin (IL)-6 levels is an investigational approach to the assessment of disease activity.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Hematology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A normochromic anemia is generally present prior to therapy and improves promptly after the institution of glucocorticoids. Many patients have a reactive thrombocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/51,52\">",
"     51,52",
"    </a>",
"    ]. The leukocyte count is usually normal, even in the setting of widespread systemic inflammation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Serum albumin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The serum albumin level is often moderately decreased at diagnosis but responds quickly to the institution of glucocorticoids.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h3\">",
"     Hepatic enzymes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated serum concentrations of hepatic enzymes, such as aspartate aminotransferase and alkaline phosphatase, occur in 25 to 35 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/53\">",
"     53",
"    </a>",
"    ]. The elevations are typically modest and revert to normal with glucocorticoid therapy. Liver biopsy has shown nonspecific changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h3\">",
"     ESR",
"    </span>",
"    &nbsp;&mdash;&nbsp;A characteristic laboratory abnormality seen in most patients with GCA is a high erythrocyte sedimentation rate (ESR), which often reaches 100",
"    <span class=\"nowrap\">",
"     mm/hour",
"    </span>",
"    or more [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/1,54,55\">",
"     1,54,55",
"    </a>",
"    ]. However, less striking elevation or even normal values may be seen even before glucocorticoid therapy has begun. The following observations illustrate the range of findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a meta-analysis that included 941 biopsy-proven cases of GCA with data on ESR, only 4 percent of those with positive biopsies had a normal ESR (as defined by the local laboratory) [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/1\">",
"       1",
"      </a>",
"      ]. A normal ESR diminished the probability of a positive temporal artery biopsy by a factor of five [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A population-based study of 167 patients from Olmsted County yielded important data related to the likelihood of a low ESR in the setting of GCA [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/54\">",
"       54",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Eighteen (11 percent) had an ESR less than 50",
"      <span class=\"nowrap\">",
"       mm/hour",
"      </span>",
"      before treatment was initiated. In another series of 173 biopsy-proven cases, 12 patients (5.8 percent) had ESR values less than 46",
"      <span class=\"nowrap\">",
"       mm/hour",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/55\">",
"       55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Nine (5 percent) had an ESR less than 40",
"      <span class=\"nowrap\">",
"       mm/hour.",
"      </span>",
"     </li>",
"     <li>",
"      The patients with an ESR less than 40",
"      <span class=\"nowrap\">",
"       mm/hour",
"      </span>",
"      were less likely to experience systemic symptoms such as malaise, fever, or weight loss. However, their clinical manifestations, including risk of visual loss, were indistinguishable from those in patients with a higher ESR.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h3\">",
"     C-reactive protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum CRP levels in GCA tend to parallel those of the ESR. The clinical utility of each test varies from patient to patient. Disease activity correlates more closely with serum CRP in some patients and more closely with the ESR in others. In addition, among patients with a paraproteinemia or some other cause of a spuriously elevated or depressed ESR, the CRP level may be more reliable [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=see_link&amp;anchor=H8#H8\">",
"     \"Acute phase reactants\", section on 'Clinical relevance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The usual practice is to measure both the ESR and CRP and to factor data from both tests into the clinical assessment of the patient. Although both tests are helpful in making clinical decisions, treatment is seldom determined solely by the levels of these acute phase reactants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/26/34217?source=see_link&amp;anchor=H10#H10\">",
"     \"Treatment of giant cell (temporal) arteritis\", section on 'Monitoring and gauging disease activity'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h3\">",
"     Interleukin-6",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated serum IL-6 concentrations appear to be related closely to clinical disease activity in GCA [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/56\">",
"     56",
"    </a>",
"    ] and may be more closely correlated with clinical relapse than the ESR [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/57\">",
"     57",
"    </a>",
"    ]. However, IL-6 assays are not routinely available, and their clinical utility remains to be proven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     Risk of cranial ischemic events",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of certain symptoms",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    laboratory abnormalities suggestive of a heightened inflammatory status (fever, weight loss, ESR greater than 85",
"    <span class=\"nowrap\">",
"     mm/hour,",
"    </span>",
"    and a hemoglobin concentration less than 11",
"    <span class=\"nowrap\">",
"     g/dL)",
"    </span>",
"    may be associated with a reduced risk of developing cranial ischemic events such as vision loss [",
"    <a class=\"abstract\" href=\"UTD.htm?18/33/18969/abstract/52,58\">",
"     52,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the possibility of an association between a low inflammatory state and an increased risk of cranial ischemic events is intriguing, it is of little use in the individual patient, and there is another possible explanation for these findings: indicators of an enhanced systemic inflammatory response lead the clinician to earlier diagnosis and the prevention of ischemic events through the institution of appropriate therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/24/42369?source=see_link\">",
"       \"Patient information: Polymyalgia rheumatica and giant cell arteritis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?43/22/44389?source=see_link\">",
"       \"Patient information: Vasculitis (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/54/42852?source=see_link\">",
"       \"Patient information: Polymyalgia rheumatica and giant cell (temporal) arteritis (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14404984\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Giant cell arteritis (GCA) is a chronic vasculitis of large- and medium-sized vessels. The greatest risk factor for developing GCA is aging. The disease almost never occurs before age 50, and its incidence rises steadily thereafter. Although systemic manifestations are characteristic of GCA and although vascular involvement may be widespread, blood vessel inflammation most frequently involves the cranial branches of the arteries that originate from the aortic arch. The most feared complication of GCA, visual loss, is one potential result of the cranial arteritis associated with this disease. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A combination of features is characteristic of GCA. Among patients with a diagnosis of some form of vasculitis, the presence of three of the following five criteria is associated with a 94 percent sensitivity and a 91 percent specificity for the diagnosis of GCA (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification criteria'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Age greater than or equal to 50 years at time of disease onset",
"     </li>",
"     <li>",
"      Localized headache of new onset",
"     </li>",
"     <li>",
"      Tenderness or decreased pulse of the temporal artery",
"     </li>",
"     <li>",
"      Erythrocyte sedimentation rate (ESR) greater than 50",
"      <span class=\"nowrap\">",
"       mm/hour",
"      </span>",
"     </li>",
"     <li>",
"      Biopsy revealing a necrotizing arteritis with a predominance of mononuclear cells or a granulomatous process with multinucleated giant cells",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The onset of symptoms in GCA tends to be gradual, but abrupt presentations occur in some patients. When taking the patient&rsquo;s history, the clinician must ask about the following types of symptoms: systemic symptoms, such as fever, fatigue, and weight loss; headache; jaw claudication, which is the most specific symptom of GCA; visual symptoms; and symptoms of polymyalgia rheumatica. Other symptoms may also be present. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H22\">",
"       'Musculoskeletal findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with GCA often appear chronically ill. In addition, specific findings related to involvement of characteristic arteries may be present, including the temporal artery, large-vessel disease, and the vessels of the eye. One-third of patients with biopsy-proven GCA have normal temporal arteries on clinical examination. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A variety of ocular syndromes are associated with GCA. The most common are amaurosis fugax and anterior ischemic optic neuropathy. It is estimated that bilateral blindness will develop in 25 to 50 percent of untreated patients who present with loss of vision in one eye. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Specific visual syndromes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory findings that are useful in the assessment of GCA include routine hematological testing, selected serum chemistry tests, ESR, and C-reactive protein (CRP). (See",
"      <a class=\"local\" href=\"#H35\">",
"       'Laboratory findings'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/1\">",
"      Smetana GW, Shmerling RH. Does this patient have temporal arteritis? JAMA 2002; 287:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/2\">",
"      Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41:778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/3\">",
"      Evans JM, Bowles CA, Bjornsson J, et al. Thoracic aortic aneurysm and rupture in giant cell arteritis. A descriptive study of 41 cases. Arthritis Rheum 1994; 37:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/4\">",
"      Klein RG, Hunder GG, Stanson AW, Sheps SG. Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 1975; 83:806.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/5\">",
"      Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33:1122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/6\">",
"      G&eacute;n&eacute;reau T, Lortholary O, Pottier MA, et al. Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study Group. Arthritis Rheum 1999; 42:2674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/7\">",
"      Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995; 123:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/8\">",
"      Ostberg G. An arteritis with special reference to polymyalgia arteritica. Acta Pathol Microbiol Scand Suppl 1973; 237:Suppl 237:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/9\">",
"      Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. Arthritis Rheum 1981; 24:1414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/10\">",
"      Liozon E, Boutros-Toni F, Ly K, et al. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course. J Rheumatol 2003; 30:1272.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/11\">",
"      Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, et al. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005; 84:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/12\">",
"      Gabriel SE, O'Fallon WM, Achkar AA, et al. The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis. J Rheumatol 1995; 22:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/13\">",
"      Hall S, Persellin S, Lie JT, et al. The therapeutic impact of temporal artery biopsy. Lancet 1983; 2:1217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/14\">",
"      Miller NR. Visual manifestations of temporal arteritis. Rheum Dis Clin North Am 2001; 27:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/15\">",
"      Aiello PD, Trautmann JC, McPhee TJ, et al. Visual prognosis in giant cell arteritis. Ophthalmology 1993; 100:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/16\">",
"      Brooks RC, McGee SR. Diagnostic dilemmas in polymyalgia rheumatica. Arch Intern Med 1997; 157:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/17\">",
"      Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol 1996; 35:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/18\">",
"      Salvarani C, Hunder GG. Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis. Arthritis Rheum 1999; 42:1259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/19\">",
"      Paira S, Graf C, Roverano S, Rossini J. Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases. Clin Rheumatol 2002; 21:146.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/20\">",
"      Olopade CO, Sekosan M, Schraufnagel DE. Giant cell arteritis manifesting as chronic cough and fever of unknown origin. Mayo Clin Proc 1997; 72:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/21\">",
"      Brack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999; 42:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/22\">",
"      Nuenninghoff DM, Hunder GG, Christianson TJ, et al. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003; 48:3522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/23\">",
"      Ninet JP, Bachet P, Dumontet CM, et al. Subclavian and axillary involvement in temporal arteritis and polymyalgia rheumatica. Am J Med 1990; 88:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/24\">",
"      Agard C, Barrier JH, Dupas B, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 2008; 59:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/25\">",
"      Gonzalez-Gay MA, Garcia-Porrua C, Pi&ntilde;eiro A, et al. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study. Medicine (Baltimore) 2004; 83:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/26\">",
"      Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 1995; 122:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/27\">",
"      Garc&iacute;a-Mart&iacute;nez A, Hern&aacute;ndez-Rodr&iacute;guez J, Arguis P, et al. Development of aortic aneurysm/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients. Arthritis Rheum 2008; 59:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/28\">",
"      Salvarani C, Giannini C, Miller DV, Hunder G. Giant cell arteritis: Involvement of intracranial arteries. Arthritis Rheum 2006; 55:985.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/29\">",
"      Wilkinson IM, Russell RW. Arteries of the head and neck in giant cell arteritis. A pathological study to show the pattern of arterial involvement. Arch Neurol 1972; 27:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/30\">",
"      Haga HJ, Eide GE, Brun J, et al. Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993; 20:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/31\">",
"      Caselli RJ, Hunder GG, Whisnant JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/32\">",
"      Caselli RJ, Hunder GG. Neurologic complications of giant cell (temporal) arteritis. Semin Neurol 1994; 14:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/33\">",
"      Lie JT. Aortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentation. Semin Arthritis Rheum 1995; 24:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/34\">",
"      R&uuml;egg S, Engelter S, Jeanneret C, et al. Bilateral vertebral artery occlusion resulting from giant cell arteritis: report of 3 cases and review of the literature. Medicine (Baltimore) 2003; 82:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/35\">",
"      Healey LA, Wilske KR. Presentation of occult giant cell arteritis. Arthritis Rheum 1980; 23:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/36\">",
"      Hellmann DB. Temporal arteritis: a cough, toothache, and tongue infarction. JAMA 2002; 287:2996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/37\">",
"      Kariv R, Sidi Y, Gur H. Systemic vasculitis presenting as a tumorlike lesion. Four case reports and an analysis of 79 reported cases. Medicine (Baltimore) 2000; 79:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/38\">",
"      Amor-Dorado JC, Llorca J, Garcia-Porrua C, et al. Audiovestibular manifestations in giant cell arteritis: a prospective study. Medicine (Baltimore) 2003; 82:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/39\">",
"      Lee CC, Su WW, Hunder GG. Dysarthria associated with giant cell arteritis. J Rheumatol 1999; 26:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/40\">",
"      Scola CJ, Li C, Upchurch KS. Mesenteric involvement in giant cell arteritis. An underrecognized complication? Analysis of a case series with clinicoanatomic correlation. Medicine (Baltimore) 2008; 87:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/41\">",
"      Manna R, Cristiano G, Todaro L, et al. Microscopic haematuria: a diagnostic aid in giant-cell arteritis? Lancet 1997; 350:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/42\">",
"      Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med 1982; 97:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/43\">",
"      BIRKHEAD NC, WAGENER HP, SHICK RM. Treatment of temporal arteritis with adrenal corticosteroids; results in fifty-five cases in which lesion was proved at biopsy. J Am Med Assoc 1957; 163:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/44\">",
"      Guyer DR, Miller NR, Auer CL, Fine SL. The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy. Arch Ophthalmol 1985; 103:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/45\">",
"      Sch&auml;uble B, Wijman CA, Koleini B, Babikian VL. Ophthalmic artery microembolism in giant cell arteritis. J Neuroophthalmol 2000; 20:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/46\">",
"      Appen RE, Wray SH, Cogan DG. Central retinal artery occlusion. Am J Ophthalmol 1975; 79:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/47\">",
"      Mohan K, Gupta A, Jain IS, Banerjee CK. Bilateral central retinal artery occlusion in occult temporal arteritis. J Clin Neuroophthalmol 1989; 9:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/48\">",
"      Eagling EM, Sanders MD, Miller SJ. Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases. Br J Ophthalmol 1974; 58:990.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/49\">",
"      Spencer WH, Hoyt WF. A fatal case of giant cell arteritis (temporal or cranial arteritis) with ocular involvement. Arch Ophthalmol 1960; 64:862.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/50\">",
"      Razavi M, Jones RD, Manzel K, et al. Steroid-responsive charles bonnet syndrome in temporal arteritis. J Neuropsychiatry Clin Neurosci 2004; 16:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/51\">",
"      Foroozan R, Danesh-Meyer H, Savino PJ, et al. Thrombocytosis in patients with biopsy-proven giant cell arteritis. Ophthalmology 2002; 109:1267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/52\">",
"      Gonzalez-Gay MA, Lopez-Diaz MJ, Barros S, et al. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine (Baltimore) 2005; 84:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/53\">",
"      Hazleman B. Laboratory investigations useful in the evaluation of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). Clin Exp Rheumatol 2000; 18:S29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/54\">",
"      Salvarani C, Hunder GG. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum 2001; 45:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/55\">",
"      Liozon E, Jauberteau-Marchan MO, Ly K, et al. Giant cell arteritis with a low erythrocyte sedimentation rate: comments on the article by Salvarani and Hunder. Arthritis Rheum 2002; 47:692.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/56\">",
"      Roche NE, Fulbright JW, Wagner AD, et al. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. Arthritis Rheum 1993; 36:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/57\">",
"      Weyand CM, Fulbright JW, Hunder GG, et al. Treatment of giant cell arteritis: interleukin-6 as a biologic marker of disease activity. Arthritis Rheum 2000; 43:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?18/33/18969/abstract/58\">",
"      Cid MC, Font C, Oristrell J, et al. Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis. Arthritis Rheum 1998; 41:26.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8225 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-5115C1355F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18969=[""].join("\n");
var outline_f18_33_18969=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14404984\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION CRITERIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Systemic complaints",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Headache",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Jaw claudication",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Visual symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Polymyalgia rheumatica",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Other musculoskeletal symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Upper respiratory tract",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Arm claudication",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Aneurysms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Central nervous system involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Other manifestations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Pulses",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Temporal artery abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Eye examination",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Musculoskeletal findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Bruits",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Cardiac auscultation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Specific visual syndromes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Amaurosis fugax",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Anterior ischemic optic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Central retinal artery occlusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Diplopia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Posterior ischemic optic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Branch retinal artery occlusion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Bitemporal hemianopia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Homonymous hemianopia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Visual hallucinations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Laboratory findings",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Hematology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Serum albumin",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      - Hepatic enzymes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      - ESR",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      - C-reactive protein",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      - Interleukin-6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      Risk of cranial ischemic events",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14404984\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/8225\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8225|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?6/12/6343\" title=\"diagnostic image 1\">",
"      Left subclavian artery GCA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?30/52/31566\" title=\"diagnostic image 2\">",
"      Thoracic aortic aneurysm in giant cell arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8225|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/61/43998\" title=\"picture 1\">",
"      Enlarged temporal artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?20/46/21230\" title=\"picture 2\">",
"      Ischemic optic disc in GCA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/8225|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/7/9341\" title=\"table 1\">",
"      Features giant cell arteritis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/42/38569?source=related_link\">",
"      Acute phase reactants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/26/10666?source=related_link\">",
"      Amaurosis fugax (transient monocular or binocular visual loss)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/50/3882?source=related_link\">",
"      Central and branch retinal artery occlusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13832?source=related_link\">",
"      Clinical manifestations and diagnosis of polymyalgia rheumatica",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/50/34599?source=related_link\">",
"      Diagnosis of giant cell (temporal) arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/61/37848?source=related_link\">",
"      Homonymous hemianopia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/47/27386?source=related_link\">",
"      Major side effects of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/62/8166?source=related_link\">",
"      Pathogenesis of giant cell (temporal) arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/54/42852?source=related_link\">",
"      Patient information: Polymyalgia rheumatica and giant cell (temporal) arteritis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/24/42369?source=related_link\">",
"      Patient information: Polymyalgia rheumatica and giant cell arteritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?43/22/44389?source=related_link\">",
"      Patient information: Vasculitis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/26/34217?source=related_link\">",
"      Treatment of giant cell (temporal) arteritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32886?source=related_link\">",
"      Visual release hallucinations (Charles Bonnet syndrome)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f18_33_18970="Patient consent form - page 1";
var content_f18_33_18970=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F61018%7EPC%2F72823%7EPC%2F51850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F61018%7EPC%2F72823%7EPC%2F51850&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 587px\">",
"   <div class=\"ttl\">",
"    Patient consent form - page 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 567px; height: 721px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 587px\">",
"   <div class=\"ttl\">",
"    Patient consent form - page 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 567px; height: 790px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 587px\">",
"   <div class=\"ttl\">",
"    Patient consent form - page 3",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 567px; height: 284px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18970=[""].join("\n");
var outline_f18_33_18970=null;
var title_f18_33_18971="Variation in public support PAS";
var content_f18_33_18971=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F67869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F67869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Variations in the public's support for euthanasia and physician-assisted suicide by scenario and intervention",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Scenario: terminally ill",
"patient with:",
"       </td>",
"       <td class=\"subtitle1\">",
"        Support for euthanasia, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        Support for physician-assisted",
"suicide, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Unremitting pain despite narcotics, nerve blocks and",
"other pain treatments.",
"       </td>",
"       <td>",
"        65.6",
"       </td>",
"       <td>",
"        66.5",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Functional debility - no pain but cannot get out of bed",
"or provide self-care.",
"       </td>",
"       <td>",
"        49.2",
"       </td>",
"       <td>",
"        48.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Burden on family - has no pain but concerned about the",
"burden that deterioration might place on the family.",
"       </td>",
"       <td>",
"        36.2",
"       </td>",
"       <td>",
"        36.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        View life as meaningless - has no pain but finds",
"waiting for death meaningless and purposeless",
"       </td>",
"       <td>",
"        29.3",
"       </td>",
"       <td>",
"        32.8",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Emanuel, EJ, Fairclough, DL, Daniels, ER, Clarridge, BR, Lancet 1996; 347:1805.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18971=[""].join("\n");
var outline_f18_33_18971=null;
var title_f18_33_18972="Treatment of visceral leishmaniasis";
var content_f18_33_18972=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F80899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F80899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Treatment of visceral leishmaniasis in adults",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       &nbsp;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Preferred therapy and duration",
"      </td>",
"      <td class=\"subtitle1\">",
"       Alternative therapy",
"      </td>",
"      <td class=\"subtitle1\">",
"       Other options/issues",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       VL in previously immunocompetent patient",
"      </td>",
"      <td>",
"       <p>",
"        Liposomal amphotericin B 3 mg/kg IV on days 1-5, 14 and 21; or",
"       </p>",
"       <p>",
"        3 mg/kg/day x 7-10 days; or",
"       </p>",
"       <p>",
"        10 mg/kg/day x 2 days",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Amphotericin B desoxycholate 0.75-1.0 mg/kg IV every other day for 30 days; or",
"       </p>",
"       <p>",
"        Sodium stibogluconate* 20 mg/kg IV or IM daily x 28 days",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Nutritional support, treatment of hemorrhagic or infectious complications",
"       </p>",
"       <p>",
"        Miltefosine&bull; 2.5 mg/kg/day PO x 28 days",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       HIV-VL coinfection",
"      </td>",
"      <td>",
"       <p>",
"        Liposomal amphotericin B 2-4 mg/kg IV daily x 10 days; or",
"       </p>",
"       <p>",
"        Interrupted schedule (e.g. 4 mg/kg on days 1-5, 10, 17, 24, 31, 38) to achieve total dose of 20-60 mg/kg",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        Amphotericin B desoxycholate 0.5-1.0 mg/kg IV QD for total dose of 1.5-2.0 grams; or",
"       </p>",
"       <p>",
"        Sodium stibogluconate* 20 mg/kg IV or IM daily x 28 days",
"       </p>",
"      </td>",
"      <td>",
"       <p>",
"        ART should be initiated or optimized",
"       </p>",
"       <p>",
"        Alternative regimen for treatment failure: Miltefosine&bull; 2.5 mg/kg/day PO x 28 days",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Secondary prophylaxis: Liposomal amphotericin B 4 mg/kg every 2 to 4 weeks",
"      </td>",
"      <td>",
"       Secondary prophylaxis: Sodium stibogluconate* 20 mg/kg IV or IM every 4 weeks",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Post kala-azar dermal leishmaniasis",
"      </td>",
"      <td>",
"       Sodium stibogluconate* 20 mg/kg/day IV or IM x 60-120 days (usually given in 20 day courses with 10 day rest periods)",
"      </td>",
"      <td>",
"       Amphotericin B deoxycholate 1 mg/kg/day x 60 days (20-day courses with 20-day rest periods)",
"      </td>",
"      <td>",
"       Miltefosine&bull; 2.5 mg/kg/day PO x 12 weeks",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Available from CDC Division of Parasitic Diseases (Contact 404-718-4745; email parasites@cdc.gov, CDC Drug Service (404-639-3670), or for emergencies outside of business hours, CDC Emergency Operations Center (770-488-7100).",
"     <br>",
"      &bull; Not currently available in the United States.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18972=[""].join("\n");
var outline_f18_33_18972=null;
var title_f18_33_18973="Benefit of LTOT in MRC";
var content_f18_33_18973=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F67353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F67353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Survival benefit of long-term oxygen therapy in COPD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 420px; height: 243px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medical Research Council Trial in which 87 patients with chronic obstructive pulmonary disease, severe hypoxemia, hypercapnia, and a history of heart failure were randomized to treatment with oxygen therapy for at least 15 h/day (blue dashed line) or no oxygen (red line). Continuous oxygen therapy led to a significant survival benefit.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Report of the Medical Research Council Working Party, Lancet 1981; 1:681.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18973=[""].join("\n");
var outline_f18_33_18973=null;
var title_f18_33_18974="Viruses and host factors";
var content_f18_33_18974=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F58691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F58691&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 600px\">",
"   <div class=\"ttl\">",
"    Viruses and host factors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 580px; height: 226px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Viruses interact with host susceptibility factors to promote recurrent wheeze and asthma development. The nature of these interactions are both virus and age specific. Interactions between lung and immune factors in determining the severity of viral infections and long-term outcomes (see text).",
"    <div class=\"footnotes\">",
"     AHR: airway hyperresponsiveness.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Gern, JE, Rosenthal, LA, Sorkness, RL, Lemanske, RF. Effects of viral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol 2005; 115:668. Copyright &copy; 2005. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18974=[""].join("\n");
var outline_f18_33_18974=null;
var title_f18_33_18975="Color flow mapping of aortic dissection";
var content_f18_33_18975=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F69102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F69102&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Color flow mapping of aortic dissection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Color flow mapping of type B dissection of the descending thoracic aorta using transesophageal echocardiography (0&deg; crystal orientation). The red and blue color indicates blood flow in the true lumen, while the lack of color indicates little or no flow in the surrounding false lumen (FL).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Warren Manning, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f18_33_18975=[""].join("\n");
var outline_f18_33_18975=null;
